<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" xml:lang="en" article-type="review-article"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Viruses</journal-id><journal-id journal-id-type="iso-abbrev">Viruses</journal-id><journal-id journal-id-type="publisher-id">viruses</journal-id><journal-title-group><journal-title>Viruses</journal-title></journal-title-group><issn pub-type="epub">1999-4915</issn><publisher><publisher-name>MDPI</publisher-name></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmc">PMC11680302</article-id><article-id pub-id-type="doi">10.3390/v16121809</article-id><article-id pub-id-type="publisher-id">viruses-16-01809</article-id><article-categories><subj-group subj-group-type="heading"><subject>Review</subject></subj-group></article-categories><title-group><article-title>Modulation of Monocyte Effector Functions and Gene Expression by Human Cytomegalovirus Infection</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Planchon</surname><given-names>Matthew S.</given-names></name><xref rid="af1-viruses-16-01809" ref-type="aff">1</xref><xref rid="af2-viruses-16-01809" ref-type="aff">2</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-2671-3311</contrib-id><name><surname>Fishman</surname><given-names>Jay A.</given-names></name><xref rid="af3-viruses-16-01809" ref-type="aff">3</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0003-1498-1703</contrib-id><name><surname>El Khoury</surname><given-names>Joseph</given-names></name><xref rid="af1-viruses-16-01809" ref-type="aff">1</xref><xref rid="af3-viruses-16-01809" ref-type="aff">3</xref><xref rid="c1-viruses-16-01809" ref-type="corresp">*</xref></contrib></contrib-group><contrib-group><contrib contrib-type="editor"><name><surname>Abate</surname><given-names>Davide</given-names></name><role>Academic Editor</role></contrib></contrib-group><aff id="af1-viruses-16-01809"><label>1</label>Center for Immunology and Inflammatory Diseases, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02129, USA; <email>matthew.planchon@students.jefferson.edu</email></aff><aff id="af2-viruses-16-01809"><label>2</label>Sidney Kimmel Medical College at Thomas Jefferson University, Philadelphia, PA 19107, USA</aff><aff id="af3-viruses-16-01809"><label>3</label>Transplant Infectious Disease and Compromised Host Program, Division of Infectious Diseases, Massachusetts General Hospital, and Harvard Medical School, Boston, MA 02114, USA; <email>jfishman@mgh.harvard.edu</email></aff><author-notes><corresp id="c1-viruses-16-01809"><label>*</label>Correspondence: <email>jelkhoury@mgh.harvard.edu</email></corresp></author-notes><pub-date pub-type="epub"><day>21</day><month>11</month><year>2024</year></pub-date><pub-date pub-type="collection"><month>12</month><year>2024</year></pub-date><volume>16</volume><issue>12</issue><elocation-id>1809</elocation-id><history><date date-type="received"><day>03</day><month>10</month><year>2024</year></date><date date-type="rev-recd"><day>15</day><month>11</month><year>2024</year></date><date date-type="accepted"><day>19</day><month>11</month><year>2024</year></date></history><permissions><copyright-statement>&#x000a9; 2024 by the authors.</copyright-statement><copyright-year>2024</copyright-year><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (<ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">https://creativecommons.org/licenses/by/4.0/</ext-link>).</license-p></license></permissions><abstract><p>Monocytes are crucial players in innate immunity. The human cytomegalovirus (CMV) infection has significant impacts on monocyte effector functions and gene expression. CMV, a &#x003b2;-herpesvirus, disrupts key monocyte roles, including phagocytosis, antigen presentation, cytokine production, and migration, impairing their ability to combat pathogens and activate adaptive immune responses. CMV modulates monocyte gene expression, decreasing their capacity for antigen presentation and phagocytosis while increasing pro-inflammatory cytokine production, which can contribute to tissue damage and chronic inflammation. CMV also alters monocyte migration to sites of infection while promoting trans-endothelial migration, thus aiding viral dissemination. Additionally, the virus affects reactive oxygen species (ROS) production, thereby contributing to end-organ disease associated with CMV infection. Overall, these changes enhance viral persistence during acute infection and facilitate immune evasion during latency. We highlight the clinical significance of these disruptions, particularly in immunocompromised patients such as transplant recipients, where the modulation of monocyte function by CMV exacerbates risks for infection, inflammation, and graft rejection. An understanding of these mechanisms will inform therapeutic strategies to mitigate CMV-related complications in vulnerable populations.</p></abstract><kwd-group><kwd>cytomegalovirus</kwd><kwd>monocyte</kwd><kwd>phagocytosis</kwd><kwd>chemotaxis</kwd><kwd>migration</kwd><kwd>cytokine production</kwd><kwd>reactive oxygen species</kwd><kwd>tissue repair</kwd><kwd>antigen presentation</kwd><kwd>immunocompromised</kwd></kwd-group><funding-group><award-group><funding-source>NIAID</funding-source><award-id>U01 AI163086</award-id></award-group><award-group><funding-source>J.E.K.</funding-source></award-group><funding-statement>This research was funded by NIAID grant number U01 AI163086. And The APC was funded by J.E.K.</funding-statement></funding-group></article-meta></front><body><sec sec-type="intro" id="sec1-viruses-16-01809"><title>1. Introduction</title><p>Human cytomegalovirus (CMV) is a ubiquitous DNA &#x003b2;-herpesvirus found worldwide. The global seroprevalence of CMV is estimated to be 56&#x02013;94%, with differences dependent on country of origin and socio-economic status of infected individuals [<xref rid="B1-viruses-16-01809" ref-type="bibr">1</xref>]. CMV infects many cell types, including epithelial cells in the oropharynx, vascular endothelial cells, hepatocytes, fibroblasts, smooth muscle cells, monocytes, macrophages, and dendritic cells. CMV enters the cell nucleus as an episomal element. Like other herpesviruses, CMV establishes lifelong infection, including latent infection in myeloid cells of the bone marrow, where the outcome of infection depends on the cell type [<xref rid="B2-viruses-16-01809" ref-type="bibr">2</xref>,<xref rid="B3-viruses-16-01809" ref-type="bibr">3</xref>]. Virally encoded proteins from virions or expressed in the cell during active infection, latency, or reactivation, control cellular functions necessary for further viral replication and spread [<xref rid="B4-viruses-16-01809" ref-type="bibr">4</xref>]. For example, CMV generally causes lytic infection in fibroblasts, while in myeloid progenitor cells, the initial burst of lytic gene expression is followed by viral latency, allowing infected monocytes to spread the virus systemically. In immunocompetent individuals, the host immune response controls acute CMV infection, which is generally limited to asymptomatic or mild mononucleosis-like symptoms. In the absence of a fully functioning immune system, as in individuals following solid organ or bone marrow transplant (SOT or BMT) or with uncontrolled HIV infection, acute CMV infection or the reactivation of latent virus can be associated with viral replication leading to end-organ disease (EOD) and may contribute to rejection of transplanted organs [<xref rid="B5-viruses-16-01809" ref-type="bibr">5</xref>]. Additionally, primary CMV infection during pregnancy poses a risk for congenital birth defects including neonatal hearing loss, microcephaly, and other neurodevelopmental conditions [<xref rid="B6-viruses-16-01809" ref-type="bibr">6</xref>].</p><p>Monocytes and macrophages are major components of the innate immune system and are important targets for primary CMV infection and reactivation [<xref rid="B7-viruses-16-01809" ref-type="bibr">7</xref>]. Here we focus on reviewing the changes in gene expression and cell function associated with CMV infection/reactivation in monocytes and macrophages and highlighting the importance of these changes in the setting of SOT recipients.</p></sec><sec id="sec2-viruses-16-01809"><title>2. Monocyte Functions</title><p>Monocytes are bone marrow-derived circulating immune cells responsible for many innate immune responses. There are three major subsets of human monocytes classified based on the relative expression of the cell surface markers CD14 and CD16: classical (CD14++, CD16&#x02212;), intermediate (CD14+, CD16+), and nonclassical (CD14+, CD16++) monocytes [<xref rid="B8-viruses-16-01809" ref-type="bibr">8</xref>]. Additionally, monocyte cell subsets are differentiated based on function (<xref rid="viruses-16-01809-f001" ref-type="fig">Figure 1</xref>). Classical monocytes are the most prevalent subtype and are predominantly responsible for phagocytosis and antigen presentation. Intermediate monocytes are the next most prevalent subtype, and mediate inflammation through the generation of reactive oxygen and nitrogen species (ROS and RNS), antigen presentation for adaptive immune responses, and T cell activation. Non-classical monocytes share similar functions with intermediate monocytes; these include secreting cytokines, activating T cells, and functioning in antigen presentation [<xref rid="B9-viruses-16-01809" ref-type="bibr">9</xref>,<xref rid="B10-viruses-16-01809" ref-type="bibr">10</xref>]. A potential fourth subset has been described in the literature based on single cell RNASeq data [<xref rid="B11-viruses-16-01809" ref-type="bibr">11</xref>]. This subset combines parts of classical monocyte gene expression with a cytotoxic killing profile dictated by perforin 1 (PRF1), granulysin (GNLY), and cathepsin W (CTSW) expression. This subset of monocytes with significant cytotoxic killing ability is not yet well described in the literature and could contribute to monocyte adaptive immunity.</p><p>Monocytes are crucial effectors in infection. In acute infections, monocytes migrate into tissues where they can differentiate into macrophages and dendritic cells [<xref rid="B9-viruses-16-01809" ref-type="bibr">9</xref>]. Additionally, the vascular and neural accumulation of monocytes plays a role in the pathogenesis of many chronic and inflammatory diseases including atherosclerosis, Alzheimer&#x02019;s disease, and multiple sclerosis [<xref rid="B12-viruses-16-01809" ref-type="bibr">12</xref>,<xref rid="B13-viruses-16-01809" ref-type="bibr">13</xref>,<xref rid="B14-viruses-16-01809" ref-type="bibr">14</xref>]. Monocytes are crucial in CMV pathogenesis in part due to their differentiation into macrophages within tissues. The lifespan of monocytes in circulation is short at approximately three weeks. However, differentiation into macrophages increases their life span to years [<xref rid="B15-viruses-16-01809" ref-type="bibr">15</xref>]. The longevity of macrophages provides a stable reservoir for CMV persistence in multiple tissues and is responsible for clinical latency [<xref rid="B1-viruses-16-01809" ref-type="bibr">1</xref>].</p><p>Monocyte polarization in response to a variety of stimuli has been extensively studied [<xref rid="B16-viruses-16-01809" ref-type="bibr">16</xref>]. A commonly used classification is the M1/M2 classification. While this classification has been useful, subsequent research showed that it is too simplistic and does not reflect the various polarized states of monocytes and macrophages [<xref rid="B17-viruses-16-01809" ref-type="bibr">17</xref>].</p><p>Monocytes are versatile immune cells that perform several critical functions in the immune response (<xref rid="viruses-16-01809-f001" ref-type="fig">Figure 1</xref>). These functions include:
<list list-type="simple"><list-item><label>A.</label><p><italic toggle="yes">Phagocytosis:</italic> Monocytes can engulf and digest self- and non-self particles including pathogens and debris.</p></list-item><list-item><label>B.</label><p><italic toggle="yes">Antigen Presentation:</italic> Monocytes directly present antigens to T cells and can differentiate into macrophages and dendritic cells which are antigen-presenting cells, initiating adaptive immune responses.</p></list-item><list-item><label>C.</label><p><italic toggle="yes">Cytokine Production:</italic> Monocytes produce cytokines and chemokines that modulate the immune response.</p></list-item><list-item><label>D.</label><p><italic toggle="yes">Chemotaxis:</italic> Monocytes migrate to sites of infection or injury in response to chemokine signals.</p></list-item><list-item><label>E.</label><p><italic toggle="yes">Tissue Repair:</italic> Monocyte-derived macrophages and dendritic cells have specialized functions in tissue repair and immune regulation.</p></list-item><list-item><label>F.</label><p><italic toggle="yes">ROS and RNS Production:</italic> Monocytes produce ROS and RNS involved in host defense and tissue damage.</p></list-item></list></p><sec id="sec2dot1-viruses-16-01809"><title>2.1. Phagocytosis</title><p>Monocytes are among the first responders to infection or tissue damage. Phagocytosis, the ingestion and destruction of invading pathogens such as bacteria, fungi and virus infected cells, as well as apoptotic cells and cellular debris, is a fundamental function of monocytes [<xref rid="B18-viruses-16-01809" ref-type="bibr">18</xref>,<xref rid="B19-viruses-16-01809" ref-type="bibr">19</xref>,<xref rid="B20-viruses-16-01809" ref-type="bibr">20</xref>]. This action helps clear infections and initiates the process of healing and tissue repair. The engulfment of pathogens serves as a precursor to antigen presentation, a crucial step in activating the adaptive immune response. Monocytes recognize pathogens through pattern recognition receptors (PRRs) such as scavenger and toll-like receptors (TLR) [<xref rid="B21-viruses-16-01809" ref-type="bibr">21</xref>,<xref rid="B22-viruses-16-01809" ref-type="bibr">22</xref>], Fc receptors [<xref rid="B23-viruses-16-01809" ref-type="bibr">23</xref>], and complement receptors [<xref rid="B24-viruses-16-01809" ref-type="bibr">24</xref>], and initiate phagocytosis. Once a particle is recognized and the phagocytic process is initiated, a specialized vacuole, called phagosome, forms, which matures into a phagolysosome [<xref rid="B25-viruses-16-01809" ref-type="bibr">25</xref>].</p></sec><sec id="sec2dot2-viruses-16-01809"><title>2.2. Antigen Presentation</title><p>After phagocytosis, monocytes act as antigen-presenting cells (APCs), processing pathogens and presenting their antigens on the monocyte cell surface. Monocytes express major histocompatibility complex (MHC) class II molecules, which are essential for presenting exogenous antigens to CD4+ T helper cells. Additionally, monocytes can cross-present antigens on MHC class I molecules to CD8+ cytotoxic T cells, a function that is critical for antiviral immunity [<xref rid="B26-viruses-16-01809" ref-type="bibr">26</xref>]. By presenting antigens, monocytes help bridge the innate and adaptive immune systems, ensuring a more specific and sustained immune response against pathogens.</p><p>The antigen presentation capacity of monocytes is enhanced under inflammatory conditions and in response to certain stimuli. For instance, TLR7 stimulation has been shown to enhance the cross-presentation of cell-associated antigens by Ly6C+ classical monocytes [<xref rid="B27-viruses-16-01809" ref-type="bibr">27</xref>]. In the context of cancer immunotherapy, antigen-loaded monocytes can induce potent therapeutic antitumor T cell responses [<xref rid="B28-viruses-16-01809" ref-type="bibr">28</xref>]. These findings affirm monocytes&#x02019; integral role in maintaining immune surveillance and orchestrating adaptive immunity.</p><p>In addition to directly presenting antigens to lymphocytes, after migrating to tissues, monocytes differentiate into macrophages and dendritic cells, both of which are proficient antigen-presenting cells (APCs). Similar to monocytes, macrophages and dendritic cells engulf pathogens, process their proteins, and present antigenic peptides on their surface via major histocompatibility complex (MHC) molecules [<xref rid="B29-viruses-16-01809" ref-type="bibr">29</xref>,<xref rid="B30-viruses-16-01809" ref-type="bibr">30</xref>]. However, it is important to note that while monocytes can present antigens, their efficiency may be lower compared to specialized dendritic cells. The role of monocytes in antigen presentation appears to be particularly significant in inflammatory conditions and may serve as a complementary mechanism to dendritic cell-mediated antigen presentation.</p></sec><sec id="sec2dot3-viruses-16-01809"><title>2.3. Cytokine and Chemokine Production</title><p>In addition to their phagocytic and antigen-presenting capabilities, monocytes play an important role in cytokine and chemokine production, which is crucial for orchestrating immune responses. Upon activation, monocytes produce a wide array of cytokines, including tumor necrosis factor (TNF), interleukin-1 beta (IL-1&#x003b2;), IL-6, and IL-10, which modulate inflammation and immune cell recruitment. For instance, TNF and IL-1&#x003b2; are key pro-inflammatory cytokines that promote the activation and recruitment of other immune cells to sites of infection or injury [<xref rid="B31-viruses-16-01809" ref-type="bibr">31</xref>]. IL-6 plays a dual role by supporting both pro-inflammatory and anti-inflammatory pathways, depending on the context of its release [<xref rid="B32-viruses-16-01809" ref-type="bibr">32</xref>].</p><p>Chemokines are a family of small cytokines that activate G-protein-coupled receptors on monocytes. Chemokines produced by monocytes, such as monocyte chemoattractant protein-1 (CCL2/MCP-1), are essential for the recruitment of monocytes and other leukocytes to inflamed tissues. CCL2 binds to the chemokine receptor 2 (CCR2) on monocytes, facilitating their migration from the bone marrow to sites of inflammation [<xref rid="B33-viruses-16-01809" ref-type="bibr">33</xref>]. Additionally, monocytes can produce CCL5 (RANTES) and CXCL10 (IP-10), which further enhance the recruitment of T cells and other immune cells, thereby amplifying the immune response [<xref rid="B34-viruses-16-01809" ref-type="bibr">34</xref>].</p><p>The production of cytokines and chemokines by monocytes is tightly regulated and can be influenced by various factors, including pathogen-associated molecular patterns (PAMPs) and damage-associated molecular patterns (DAMPs). This regulatory mechanism ensures a balanced immune response, preventing excessive inflammation that could lead to tissue damage. Understanding the specific pathways and triggers for cytokine and chemokine production in monocytes is crucial for developing targeted therapies for inflammatory and infectious diseases [<xref rid="B35-viruses-16-01809" ref-type="bibr">35</xref>].</p></sec><sec id="sec2dot4-viruses-16-01809"><title>2.4. Chemotaxis</title><p>Chemotaxis is a crucial effector function of monocytes, enabling their directed migration towards sites of infection or inflammation. This process is primarily mediated by MCP-1/CCL2, a key chemokine regulating monocyte migration and infiltration through its interaction with its receptor, CCR2 [<xref rid="B36-viruses-16-01809" ref-type="bibr">36</xref>]. Upon activation, monocytes undergo a series of coordinated events involving the upregulation of adhesion molecules expression, cytoskeletal rearrangements, and polarization to facilitate their movement along chemokine gradients [<xref rid="B37-viruses-16-01809" ref-type="bibr">37</xref>]. The chemotactic response involves the activation of intracellular signaling cascades, including the mobilization of intracellular calcium and the activation of kinases such as PI3K and MAPK [<xref rid="B38-viruses-16-01809" ref-type="bibr">38</xref>]. These signaling events lead to the activation of integrins, which mediate firm adhesion to the endothelium, and the formation of specialized structures, like focal adhesions and the uropod, essential for directional movement [<xref rid="B37-viruses-16-01809" ref-type="bibr">37</xref>]. Importantly, chemotaxis is not only crucial for monocyte recruitment to inflammatory sites but also plays a role in their normal physiological trafficking and immune surveillance [<xref rid="B39-viruses-16-01809" ref-type="bibr">39</xref>]. Defects in monocyte chemotaxis have been associated with various pathological conditions, including acquired immune deficiency syndrome (AIDS), where impaired monocyte migration contributes to the compromised immune response [<xref rid="B39-viruses-16-01809" ref-type="bibr">39</xref>] and Alzheimer&#x02019;s disease [<xref rid="B40-viruses-16-01809" ref-type="bibr">40</xref>,<xref rid="B41-viruses-16-01809" ref-type="bibr">41</xref>]. Understanding the molecular mechanisms underlying monocyte chemotaxis is essential for developing targeted therapies for inflammatory disorders and improving our comprehension of the immune system&#x02019;s functionality.</p></sec><sec id="sec2dot5-viruses-16-01809"><title>2.5. Tissue Repair</title><p>Monocytes play a role in tissue repair through their ability to differentiate into macrophages and their direct contributions to the repair process. Recent studies have elucidated the complex interplay between monocyte subsets and their functions in various stages of tissue repair. Classical CD14++CD16&#x02212; monocytes recruited to sites of injury differentiate into inflammatory macrophages that promote debris clearance and initiate the repair cascade. These cells secrete pro-inflammatory cytokines and growth factors that stimulate angiogenesis and fibroblast activation. As the repair process progresses, there is a shift towards non-classical CD14+CD16++ monocytes, which can differentiate into reparative macrophages that support the resolution of inflammation, tissue regeneration and remodeling [<xref rid="B42-viruses-16-01809" ref-type="bibr">42</xref>].</p><p>The plasticity of monocytes and monocyte-derived macrophages is a key feature in tissue repair, allowing them to adapt their phenotype in response to environmental cues. This plasticity is particularly evident in chronic inflammatory diseases, where the balance between pro-inflammatory and pro-resolving monocyte functions can influence disease progression and tissue repair outcomes [<xref rid="B43-viruses-16-01809" ref-type="bibr">43</xref>]. Recent research has also highlighted the potential of biomaterial-based approaches to modulate monocyte behavior in tissue repair contexts, offering new avenues for therapeutic interventions [<xref rid="B44-viruses-16-01809" ref-type="bibr">44</xref>].</p><p>It is important to note that while monocytes are generally beneficial for tissue repair, their dysregulation can contribute to fibrosis and impaired healing in certain conditions. The specific roles of monocyte subsets can vary depending on the tissue type and nature of the injury, underscoring the need for context-specific investigations to fully elucidate their functions in tissue repair processes [<xref rid="B42-viruses-16-01809" ref-type="bibr">42</xref>].</p></sec><sec id="sec2dot6-viruses-16-01809"><title>2.6. ROS/RNS Production</title><p>Monocytes produce reactive oxygen species (ROS) and reactive nitrogen species (RNS) as part of their effector functions [<xref rid="B45-viruses-16-01809" ref-type="bibr">45</xref>]. ROS, including superoxide anion (O<sub>2</sub><sup>&#x02212;</sup>) and hydrogen peroxide (H<sub>2</sub>O<sub>2</sub>), are generated through the activation of the NADPH oxidase complex [<xref rid="B46-viruses-16-01809" ref-type="bibr">46</xref>,<xref rid="B47-viruses-16-01809" ref-type="bibr">47</xref>]. To effectively produce ROS and RNS, monocytes undergo metabolic alterations that contribute to monocyte activation. A metabolic shift to aerobic glycolysis [<xref rid="B48-viruses-16-01809" ref-type="bibr">48</xref>], enhanced activity of the pentose phosphate pathway, and alterations in the tricarboxylic acid (TCA) cycle help create a pro-oxidant environment [<xref rid="B49-viruses-16-01809" ref-type="bibr">49</xref>]. ROS and RNS produce positive feedback on monocytes throughout this process to further propagate the pro-inflammatory system. Initial monocyte activation occurs in response to various stimuli, such as pathogen-associated molecular patterns (PAMPs) and cytokines [<xref rid="B47-viruses-16-01809" ref-type="bibr">47</xref>]. Upon activation, NADPH oxidase transfers electrons from NADPH to oxygen, forming superoxide anions, which subsequently transform into hydrogen peroxide [<xref rid="B50-viruses-16-01809" ref-type="bibr">50</xref>]. RNS, primarily nitric oxide (NO), are synthesized by the enzyme inducible nitric oxide synthase (iNOS), which is upregulated during inflammatory responses [<xref rid="B51-viruses-16-01809" ref-type="bibr">51</xref>]. Nitric oxide can react with superoxide to form peroxynitrite (ONOO<sup>&#x02212;</sup>), a potent oxidant with antimicrobial properties [<xref rid="B52-viruses-16-01809" ref-type="bibr">52</xref>].</p><p>The production of ROS and RNS by monocytes contributes to the elimination of pathogens through oxidative and nitrosative stress, damaging microbial DNA, proteins, and lipids. This antimicrobial activity is essential for controlling infections, particularly in the early stages of the immune response. Moreover, ROS and RNS act as signaling molecules, modulating various immune functions such as cytokine production, cell proliferation, and apoptosis [<xref rid="B53-viruses-16-01809" ref-type="bibr">53</xref>]. However, excessive or uncontrolled production of ROS and RNS can lead to tissue damage and contribute to the pathogenesis of inflammatory diseases, including atherosclerosis [<xref rid="B54-viruses-16-01809" ref-type="bibr">54</xref>], rheumatoid arthritis [<xref rid="B55-viruses-16-01809" ref-type="bibr">55</xref>], Alzheimer&#x02019;s disease [<xref rid="B14-viruses-16-01809" ref-type="bibr">14</xref>,<xref rid="B56-viruses-16-01809" ref-type="bibr">56</xref>] and sepsis [<xref rid="B57-viruses-16-01809" ref-type="bibr">57</xref>].</p><p>In conclusion, the production of ROS and RNS by monocytes is a critical effector function that mediates pathogen clearance and regulates immune responses. Understanding the balance between their beneficial and detrimental effects is essential for developing therapeutic strategies to modulate immune responses in various diseases.</p></sec></sec><sec id="sec3-viruses-16-01809"><title>3. Effect of CMV on Monocyte Effector Functions</title><sec id="sec3dot1-viruses-16-01809"><title>3.1. CMV&#x02013;Monocyte Interactions</title><p>CMV utilizes receptor-initiated signal transduction in monocytes to shape the biology of these cells (<xref rid="viruses-16-01809-f002" ref-type="fig">Figure 2</xref>) [<xref rid="B58-viruses-16-01809" ref-type="bibr">58</xref>]. Indeed, the engagement of EGFR on monocytes by CMV glycoproteins is required for CMV entry and has been shown to mediate trans-endothelial migration of these cells [<xref rid="B59-viruses-16-01809" ref-type="bibr">59</xref>]. In addition, EGFR and &#x003b2;1 and &#x003b2;2 integrin engagement are necessary for monocyte motility following CMV infection [<xref rid="B60-viruses-16-01809" ref-type="bibr">60</xref>]. It is not known if one or all these interactions are responsible for modulating additional CMV-regulated monocyte effector functions.</p></sec><sec id="sec3dot2-viruses-16-01809"><title>3.2. Effect of CMV on Phagocytosis</title><p>CMV infection has been shown to modulate the phagocytic ability of monocytes (<xref rid="viruses-16-01809-f003" ref-type="fig">Figure 3</xref>) which may compromise the immune system&#x02019;s ability to handle infection. One mechanism by which CMV impacts phagocytosis is through a paradoxical effect of classical (CD14++, CD16&#x02212;) monocytes. RNA sequencing of monocytes post-CMV infection demonstrates the upregulation of viral pathogen recognition receptors (PRRs) while also demonstrating the downregulation of pathogen associated molecular pattern (PAMP)-related scavenger receptors. The specific scavenger receptors impacted include CD36, which is responsible for fungal pathogen recognition [<xref rid="B61-viruses-16-01809" ref-type="bibr">61</xref>]. The decreased expression of key phagocytotic receptors for fungi leads to a marked decreased ability to phagocytose key fungal pathogens, including <italic toggle="yes">C. albicans</italic> and <italic toggle="yes">C. neoformans</italic>, which are major contributors to morbidity in immunocompromised hosts [<xref rid="B61-viruses-16-01809" ref-type="bibr">61</xref>,<xref rid="B62-viruses-16-01809" ref-type="bibr">62</xref>]. These findings provide a molecular explanation for the increased susceptibility to fungal infections during or following infection with CMV. It remains unclear whether low level CMV reactivation associated with many types of acute illnesses is similarly involved in the risks for nosocomial fungal superinfections [<xref rid="B63-viruses-16-01809" ref-type="bibr">63</xref>].</p><p>Other studies have demonstrated that complement receptors 3 and 4, CR3 and CR4, two important modulators of fungal and bacterial phagocytosis, are downregulated in both THP-1 cell line-derived macrophages and monocyte-derived human macrophages infected with CMV [<xref rid="B64-viruses-16-01809" ref-type="bibr">64</xref>].</p><p>While published evidence demonstrates that CMV directly downregulates phagocytosis through scavenger and complement receptors, the effect of CMV infection on Fc&#x003b3;-receptor-mediated phagocytosis is not fully clear. There is evidence that CMV may modify Fc&#x003b3; receptor-mediated phagocytosis through the expression of cmvIL-10, a homologous cytokine to human interleukin-10 (hIL-10) [<xref rid="B65-viruses-16-01809" ref-type="bibr">65</xref>] produced by CMV infected cells [<xref rid="B66-viruses-16-01809" ref-type="bibr">66</xref>,<xref rid="B67-viruses-16-01809" ref-type="bibr">67</xref>], thereby altering monocyte gene expression in an autocrine or paracrine fashion. Monocytes cultured with cmvIL-10 demonstrated increased expression of Fc&#x003b3; receptors CD32 and CD64 [<xref rid="B65-viruses-16-01809" ref-type="bibr">65</xref>]. CmvIL-10 increased Fc&#x003b3;-receptor-mediated phagocytosis by monocytes similar to hIL-10 [<xref rid="B65-viruses-16-01809" ref-type="bibr">65</xref>]. The role of enhanced Fc&#x003b3;-mediated phagocytosis in monocytes in the pathogenesis of CMV disease is not clear, but it may play a role in viral dissemination. Similarly, CMV infection induces the expression of viral Fc&#x003b3;Rs, such as gp34 and gp68, which can bind to the Fc region of immunoglobulins and inhibit the activation of host Fc&#x003b3;Rs (Fc&#x003b3;RI, Fc&#x003b3;RIIA, and Fc&#x003b3;RIIIA) on monocytes and other immune cells [<xref rid="B68-viruses-16-01809" ref-type="bibr">68</xref>]. This prevents IgG-mediated triggering from activating host Fc&#x003b3;Rs, thereby impairing antibody-dependent cellular phagocytosis (ADCP) and other Fc-mediated effector functions [<xref rid="B68-viruses-16-01809" ref-type="bibr">68</xref>]. Further studies on the impacts of CMV infection on Fc&#x003b3;-mediated phagocytosis are necessary to clarify the biologic significance and implications of altering this phagocytic pathway on CMV disease and the innate immune response.</p></sec><sec id="sec3dot3-viruses-16-01809"><title>3.3. Effect of CMV on Antigen Presentation</title><p>CMV infection affects the antigen-presenting function of monocytes through multiple mechanisms (<xref rid="viruses-16-01809-f004" ref-type="fig">Figure 4</xref>). First, CMV decreases the effectiveness of antigen presentation by inhibiting the differentiation of monocytes into dendritic cells (DCs) [<xref rid="B69-viruses-16-01809" ref-type="bibr">69</xref>,<xref rid="B70-viruses-16-01809" ref-type="bibr">70</xref>,<xref rid="B71-viruses-16-01809" ref-type="bibr">71</xref>]. DCs are the major antigen-presenting cells and play a key role in continuing immune activation via signaling to T cells [<xref rid="B72-viruses-16-01809" ref-type="bibr">72</xref>]. By blocking differentiation-inducing cytokines like IL-4 and GM-CSF, CMV prevents monocyte differentiation into CD1a-positive dendritic cells [<xref rid="B69-viruses-16-01809" ref-type="bibr">69</xref>]. Monocytes are less efficient at antigen presentation than dendritic cells. Thus, inhibiting monocyte differentiation decreases antigen presentation, making the host more susceptible to infection.</p><p>Second, in the setting of acute infection, CMV downregulates the expression of major histocompatibility complex (MHC) class I and II molecules [<xref rid="B70-viruses-16-01809" ref-type="bibr">70</xref>]. Interestingly, cmvIL-10 inhibits cell surface expression of MHC I and II in stimulated monocytes in contrast to its effects on Fc-mediated phagocytosis [<xref rid="B67-viruses-16-01809" ref-type="bibr">67</xref>]. CMV can also downregulate the co-stimulatory molecules CD40 and CD80 on the surface of monocytes and immature DCs [<xref rid="B70-viruses-16-01809" ref-type="bibr">70</xref>,<xref rid="B71-viruses-16-01809" ref-type="bibr">71</xref>]. Downregulation of these co-stimulatory molecules may inhibit antigen loading of existing MHC molecules. Third, CMV expresses immune evasins, glycoproteins that interrupt classical MHC class I pathways [<xref rid="B73-viruses-16-01809" ref-type="bibr">73</xref>]. Indeed, CMV-encoded proteins, US3, US6, and US10, can retain MHC class I molecules in the ER, inhibit peptide transport by the transporter associated with antigen processing (TAP), or delay trafficking of MHC I to the cell surface [<xref rid="B74-viruses-16-01809" ref-type="bibr">74</xref>,<xref rid="B75-viruses-16-01809" ref-type="bibr">75</xref>,<xref rid="B76-viruses-16-01809" ref-type="bibr">76</xref>,<xref rid="B77-viruses-16-01809" ref-type="bibr">77</xref>,<xref rid="B78-viruses-16-01809" ref-type="bibr">78</xref>]. The combination of these effects further undermines CD4+ and CD8+ T cell immunity and may help CMV go unchecked in the settings of acute infection and reactivation. </p></sec><sec id="sec3dot4-viruses-16-01809"><title>3.4. Effect of CMV on Cytokine Production</title><p>Cytokines are crucial players in regulating immune responses and inflammation. Monocytes infected with CMV produce a mixed phenotype of pro- and anti-inflammatory cytokines (<xref rid="viruses-16-01809-f005" ref-type="fig">Figure 5</xref>). This may reflect incomplete infection of the cell population as well as various states of CMV infection. The resulting immune environment promotes pathways beneficial for viral persistence while allowing cellular CMV to evade the immune system. Pro-inflammatory cytokines IL-6 and IL-8 are increased when monocytes are incubated with UV-inactivated CMV virus, indicating cytokine production results from cellular contact with viral particles rather than new gene expression [<xref rid="B79-viruses-16-01809" ref-type="bibr">79</xref>]. Increased cytokine signaling requires the pattern recognition receptors TLR2 and CD14. It is possible that such receptors may be responsible for recognizing CMV virions (in addition to EGFR and &#x003b2;1 and &#x003b2;3 integrins) leading to inflammatory signaling, though such an interaction remains to be determined [<xref rid="B79-viruses-16-01809" ref-type="bibr">79</xref>]. Other pro-inflammatory cytokines including TNF are also increased through the activation of p38 kinase and NF-kB signaling pathways in monocytes [<xref rid="B80-viruses-16-01809" ref-type="bibr">80</xref>]; this requires further investigation as some reports show decreased TNF production with acute CMV infection or reactivation [<xref rid="B71-viruses-16-01809" ref-type="bibr">71</xref>].</p><p>In addition to increasing cytokine gene expression, further mechanisms are involved in the CMV-modified monocytic cytokine production. The binding of CMV to monocytes, and the major CMV glycoproteins gB (UL55)- and gH (UL75)-mediated signaling, upregulates the secretion of IL-1&#x003b2;. This expression required the activation of NF-kB, a transcription factor responsible for regulating IL-1&#x003b2; gene expression [<xref rid="B81-viruses-16-01809" ref-type="bibr">81</xref>]. Although more research is needed, the CMV-mediated increase in IL-1&#x003b2; expression could be linked to chronic inflammation associated with CMV infections and further complicate the analysis of CMV infection in immunocompromised hosts.</p><p>While increased pro-inflammatory cytokines may be crucial to acute infection and CMV-associated inflammatory diseases, CMV also modulates anti-inflammatory cytokines for immune evasion and latency. For example, CMV upregulates the production of IL-10, an anti-inflammatory cytokine shown to prevent the differentiation of monocytes into dendritic cells [<xref rid="B69-viruses-16-01809" ref-type="bibr">69</xref>,<xref rid="B82-viruses-16-01809" ref-type="bibr">82</xref>]. In support of this anti-inflammatory effect, recombinant cmvIL-10 inhibits IFN-&#x003b3;, IL-1&#x003b1;, IL-6, GM-CSF, and TNF production by preventing NF-&#x003ba;B signaling in monocytes [<xref rid="B67-viruses-16-01809" ref-type="bibr">67</xref>]. Furthermore, monocytes and DCs infected with CMV have a decreased production of interleukin-12, a key cytokine in Th1-mediated immunity. Decreased cytokine signaling presents another barrier to T cell activation and the cytotoxic killing of CMV.</p><p>In addition to utilizing viral proteins for downregulating cytokine production, CMV utilizes microRNA (miRNA) to decrease the expression of pro-inflammatory cytokines during latency and later infection. Through these miRNA species, CMV downregulates IKKa and IKKB signaling factors, limiting the production of pro-inflammatory cytokines IL-6 and TNF-a to remain dormant and evade host immunity [<xref rid="B83-viruses-16-01809" ref-type="bibr">83</xref>]. It is possible that cmvIL-10 and the effect of CMV generated miRNA can help spread the effects of CMV to non-infected monocytes. Thus, these modulations likely propagate the effects of CMV infection on the entire monocyte population and amplify such effect(s). </p></sec><sec id="sec3dot5-viruses-16-01809"><title>3.5. Effect of CMV on Chemotaxis</title><p>CMV-infected monocytes exhibit decreased chemokine receptor expression, which can impair migration to sites of infection or injury. These downregulated chemokine receptors include CCR1, CCR2, CCR5, and CXCR4. Such downregulation occurs even in the absence of viral gene expression and is believed to be due to increased internalization of these receptors, rather than decreased gene expression or protein degradation [<xref rid="B84-viruses-16-01809" ref-type="bibr">84</xref>]. Functionally, CMV-infected monocytes were unable to migrate toward CCL2, CCL5, CXCl12, CCL19, or CX3CL1, key chemokine modulators of adaptive immunity critical for monocyte migration and recruitment to sites of inflammation, thereby potentially compromising the host&#x02019;s ability to mount an effective immune response.</p><p>In contrast to downregulated chemokine-mediated migration, CMV-infected monocytes demonstrate increased trans-endothelial migration. This increased migration is independent of viral gene expression, and occurs in monocytes incubated with both live CMV and UV-inactivated CMV strains [<xref rid="B85-viruses-16-01809" ref-type="bibr">85</xref>]. Several mechanisms are thought to be responsible for such an increase. First, cell motility is increased [<xref rid="B85-viruses-16-01809" ref-type="bibr">85</xref>]. Second, increased monocyte adhesion to endothelial cells, a key step in both early and late stages of trans-endothelial migration, is also increased. This is due to enhanced expression of &#x003b2;1 integrin, occludin, and ZO-1, proteins involved in monocyte adhesion and diapedesis [<xref rid="B85-viruses-16-01809" ref-type="bibr">85</xref>]. Additional studies also suggest that CMV-infection of the endothelial cells, in turn, increases the migration of monocytes (<xref rid="viruses-16-01809-f006" ref-type="fig">Figure 6</xref>) [<xref rid="B86-viruses-16-01809" ref-type="bibr">86</xref>]. </p><p>It has been speculated that CMV could also impact migration through chemokinesis, a motility process independent of chemokines [<xref rid="B87-viruses-16-01809" ref-type="bibr">87</xref>]. Chemokinesis is dependent on PI(3)K and the actin cytoskeleton and requires activation and signaling via integrin and EGFR pathways. These pathways are increased as a result of CMV infection [<xref rid="B1-viruses-16-01809" ref-type="bibr">1</xref>]. These secondary pathways allow CMV-infected monocytes to migrate more effectively, even without the presence of chemotactic signaling. Downregulating chemotaxis-dependent migration while maintaining chemotactic-independent migration may help CMV evade the adaptive immune system while using it for further dissemination.</p><p>CMV can also influence chemotaxis and migration through the production of chemokine-mimics encoded in the CMV genome. Chemokine homologs are common to many viruses and provide a method of immune dissemination in acute infection. In murine CMV, viral chemokines that show similarity to host CC chemokines, MCK-1 and MCK-2, were crucial to viral dissemination through monocytes [<xref rid="B88-viruses-16-01809" ref-type="bibr">88</xref>]. Deletion of the MCK-1/MCK-2 gene resulted in decreased viremia and the failure of murine CMV dissemination to salivary glands, a common reservoir of CMV. In human CMV, UL128, a viral protein with functional similarities to human CC chemokines, promoted the recruitment and proliferation of peripheral blood mononuclear cells [<xref rid="B89-viruses-16-01809" ref-type="bibr">89</xref>]. Lastly, chemokine receptor homologs, like US28, may also promote monocyte chemotaxis through the activation of G-protein signaling cascades [<xref rid="B90-viruses-16-01809" ref-type="bibr">90</xref>,<xref rid="B91-viruses-16-01809" ref-type="bibr">91</xref>].</p><p>Based on these observations, it is clear that CMV can regulate the migration of monocytes. Decreased chemokine-mediated monocyte migration can help CMV evade the immune response while increasing viral dissemination via increased CMV-induced monocyte chemokinesis and trans-endothelial migration and in response to CMV-induced chemokine mimics. Understanding the stages of CMV infection that regulate each of these migratory functions will clarify the role of this important monocyte effector function in CMV pathogenesis.</p></sec><sec id="sec3dot6-viruses-16-01809"><title>3.6. Effect of CMV on Tissue Repair and Immune Regulation</title><p>CMV infection can have a significant impact on tissue repair. CMV-infected monocytes have reduced phagocytotic abilities, altered migration, and improper signaling of T cells. Dysregulation of these typical functions leads to improper tissue repair [<xref rid="B92-viruses-16-01809" ref-type="bibr">92</xref>]. In contrast, prolonged CMV infection can lead to a chronic inflammatory state caused by cytokines from CMV-infected monocytes. High levels of IL-6, IL-8, and IL-1&#x003b2; create a cellular environment that is less favorable to tissue regeneration [<xref rid="B81-viruses-16-01809" ref-type="bibr">81</xref>]. Adhesion to endothelial cells by CMV-infected monocytes may also contribute to excessive inflammation [<xref rid="B93-viruses-16-01809" ref-type="bibr">93</xref>]. We propose that these apparent contrasting effects on the inflammatory process appear to have additive negative effects on tissue repair.</p><p>While the transition from monocytes to macrophages is upregulated through interactions with CMV, there is an altered differentiation into CD1a-positive dendritic cells by IL-4 and GM-CSF [<xref rid="B69-viruses-16-01809" ref-type="bibr">69</xref>]. Dendritic cells differentiated from CMV-infected monocytes demonstrate an inability to secrete IL-12 in response to LPS stimulation, decreased phagocytosis, and decreased induction of TH-1 cell differentiation. Although only a subset of monocytes was infected with CMV, there was widespread disruption of GM-CSF signaling in the entire population of dendritic cells. These disruptions were due to an inhibition of STAT5 activation caused by paracrine signaling of soluble factors secreted by CMV-infected monocytes [<xref rid="B94-viruses-16-01809" ref-type="bibr">94</xref>]. Because CMV-infected dendritic cells exhibit decreased differentiation, we propose that their role in tissue repair is also dysregulated.</p></sec><sec id="sec3dot7-viruses-16-01809"><title>3.7. Effect of CMV on ROS Production</title><p>An important component of the monocytes&#x02019; host defense mechanisms is the generation of reactive oxygen species (ROS) and reactive nitrogen species (RNS). ROS include superoxide (O<sub>2</sub><sup>&#x02212;</sup>), hydrogen peroxide (H<sub>2</sub>O<sub>2</sub>), and hydroxyl radical (OH<sup>&#x02212;</sup>) [<xref rid="B95-viruses-16-01809" ref-type="bibr">95</xref>]. Within monocytes, engulfed material enters the phagolysosome where it encounters superoxide, proteases, and other molecules that can kill microbes. ROS are secreted extracellularly, where they can perform their host defense functions [<xref rid="B96-viruses-16-01809" ref-type="bibr">96</xref>]. This effector function of monocytes is important in the host&#x02019;s response to bacterial, fungal and viral pathogens [<xref rid="B97-viruses-16-01809" ref-type="bibr">97</xref>]. ROS also play a major role as cellular signaling molecules during inflammation [<xref rid="B98-viruses-16-01809" ref-type="bibr">98</xref>].</p><p>During acute infection or reactivation, CMV upregulates ROS generation even in the absence of DNA replication within monocytes. This modulation is thought to be associated with increased transduction of signaling cascades of ROS generation or through the augmentation of cytosolic factors involved in ROS generation [<xref rid="B99-viruses-16-01809" ref-type="bibr">99</xref>]. Similarly, when THP-1 cells, a human monocytic cell line, were infected with CMV, there was a significant increase in ROS generation during active CMV infection [<xref rid="B100-viruses-16-01809" ref-type="bibr">100</xref>]. Therefore, in contrast to the role of ROS in bacterial and fungal killing, the increased levels of ROS are beneficial to the establishment of CMV within the host. Increased ROS production enhances CMV gene expression, which helps promote viral establishment during acute infections [<xref rid="B101-viruses-16-01809" ref-type="bibr">101</xref>]. Additionally, oxidative stress and inflammatory responses to increased ROS may create a cellular environment more favorable to viral replication [<xref rid="B102-viruses-16-01809" ref-type="bibr">102</xref>].</p><p>In contrast to the upregulation of ROS signaling and production observed with active CMV replication in monocytes, CMV evades the immune response during latency by downregulating ROS production by macrophages. This suppressive effect on ROS production during latency is believed to be regulated by a long non-coding RNA (lncRNA) called &#x003b2;2.7. CMV variants without the &#x003b2;2.7 gene were less effective at establishing latency within host monocytes and suppressing ROS production [<xref rid="B103-viruses-16-01809" ref-type="bibr">103</xref>]. These findings suggest that the ability to downregulate ROS production in the host allows CMV to remain latent and undetected by the host immune system. CMV&#x02019;s dual effect on monocyte and macrophage ROS production links this important monocyte/macrophage effector function to two important paths involved in CMV pathogenesis in immunocompromised hosts: one path leading to replication and one leading to the establishment of life-long latency within myeloid cells.</p></sec></sec><sec id="sec4-viruses-16-01809"><title>4. Clinical Implications</title><p>The effects of cytomegalovirus (CMV) infection on monocyte effector functions have significant clinical implications, particularly in the immunosuppressed host. Solid organ transplant (SOT) patients, those with uncontrolled HIV/AIDS, and those with iatrogenic immunosuppression are at high risk of complications of CMV-related illness. Although CMV possesses many mechanisms to disrupt host immunity, the modulation of monocyte effector functions produces a paradoxical change to innate immune responses, leading to both immunosuppression (e.g., opportunistic infection) and immune stimulation (e.g., graft rejection). These dual and paradoxically opposed effects provide insight into the importance of CMV infection in active, reactivated, and latent states.</p><sec id="sec4dot1-viruses-16-01809"><title>4.1. Phagocytosis</title><p>A crucial effector function in host defense against pathogens. Monocytes are responsible for phagocytosis, with the disruption of this ability with CMV infection being important in the increased susceptibility to infection. The reduced phagocytic ability of monocytes is detrimental against clinically important and common yeasts including <italic toggle="yes">Candida albicans</italic> and <italic toggle="yes">Cryptococcus neoformans</italic>. This is associated with decreased expression of key pattern recognition receptors such as CD36, MRC1, and complement receptor 3 [<xref rid="B61-viruses-16-01809" ref-type="bibr">61</xref>]. A higher risk of invasive fungal infections is amplified in immunocompromised individuals with decreased immunity against opportunistic fungi.</p><p>Increased infections with fungal pathogens create an issue in post-SOT management. The post-transplant regime is complex with a variety of immunosuppressive, antibacterial, antiviral, and antifungal agents [<xref rid="B104-viruses-16-01809" ref-type="bibr">104</xref>]. Impaired phagocytosis of <italic toggle="yes">C. albicans</italic> and <italic toggle="yes">C. neoformans</italic>, two of the three most common fungal infections post-transplant [<xref rid="B105-viruses-16-01809" ref-type="bibr">105</xref>], may necessitate more aggressive antifungal prophylaxis in CMV-infected transplant recipients. These fungal infections in patients following SOT may increase the risk for allograft rejection (possibly associated with decreases in immunosuppression) and have a 12-month mortality of 34% and 27%, respectively [<xref rid="B105-viruses-16-01809" ref-type="bibr">105</xref>]. Strategies to restore phagocytic function in CMV-infected monocytes could potentially mitigate the indirect effects of CMV in transplantation.</p></sec><sec id="sec4dot2-viruses-16-01809"><title>4.2. Antigen Presentation</title><p>Decreased antigen presentation by monocytes in patients with CMV may have significant clinical implications. First, decreased antigen presentation will reduce the stimulation of T cell responses against both CMV and other opportunistic pathogens. CMV-infected monocytes may also exhibit increased expression of regulatory co-stimulatory molecules including CD86, potentially enhancing T cell activation in certain contexts [<xref rid="B69-viruses-16-01809" ref-type="bibr">69</xref>]. The expression of CD86 without proper antigen presentation may result in T cell anergy, increasing the risk for opportunistic (viral and fungal) infections.</p></sec><sec id="sec4dot3-viruses-16-01809"><title>4.3. Production of Pro-Inflammatory Cytokines</title><p>A major impact on monocyte effector function is the production of pro-inflammatory cytokines during acute infection and with reactivation of CMV. The upregulation of key cytokines, IL-6, IL-1&#x003b2;, and TNF-&#x003b1;, creates a pro-inflammatory environment that is significant in both acute and chronic diseases. Of major concern is that heightened levels of inflammation in SOT patients may contribute to allograft dysfunction, rejection, and graft-versus-host disease in transplant recipients.</p><p>CMV is also associated with important organ-specific infections in immunocompromised hosts including CMV colitis, retinitis, hepatitis, pneumonitis, and encephalitis. There is evidence that the pro-inflammatory cellular environment may contribute to chronic inflammatory diseases including atherogenesis, accelerated atherosclerosis in cardiac transplant recipients, and chronic lung allograft dysfunction (CLAD) in lung transplant recipients [<xref rid="B106-viruses-16-01809" ref-type="bibr">106</xref>].</p></sec><sec id="sec4dot4-viruses-16-01809"><title>4.4. Implications for Therapeutics</title><p>The impact of CMV on monocyte differentiation and function has implications on the development of therapeutic strategies. The targeting of pathways involved in monocyte differentiation and cytokine production could mitigate the impacts of CMV infection and improve clinical outcomes for affected patients. For example, therapies that inhibit the differentiation of monocytes into anti-inflammatory macrophages or enhance the phagocytic capacity of monocytes could reduce viral persistence and improve viral immune clearance [<xref rid="B107-viruses-16-01809" ref-type="bibr">107</xref>].</p><p>In conclusion, the complex modulation of monocyte effector functions by CMV has far-reaching clinical implications in transplantation. A nuanced understanding of these effects is crucial for optimizing management strategies, including antiviral therapy, immunosuppression, and the development of cellular therapies, to improve outcomes in CMV-infected transplant recipients. The immunosuppressive effects of CMV on monocytes may provide a mechanism to downregulate adaptive immune responses that would otherwise lead to clearance, thereby promoting viral persistence.</p><p>Conversely, CMV infection also induces pro-inflammatory and immunostimulatory responses in monocytes. This includes the upregulation of viral pattern recognition receptors, inflammasome components (e.g., AIM2, IFI16), pro-inflammatory mediators associated with allograft rejection and graft-versus-host disease [<xref rid="B108-viruses-16-01809" ref-type="bibr">108</xref>]. This could also lead to end-organ inflammatory-mediated diseases occurring during primary infection and reactivation, where CMV viral replication is the highest.</p><p>These divergent effects of CMV on monocyte function may be host and time dependent and suggest that the pro-inflammatory phenotype may require tailored immunosuppression strategies to mitigate the risk of allograft rejection. The heterogeneity in monocyte responses to CMV infection, as revealed by single-cell transcriptomics, suggests that personalized approaches may be needed to address the variable effects in individual patients. Understanding these CMV-mediated alterations in monocyte function opens avenues for targeted therapies. Strategies to restore phagocytic function or modulate inflammatory responses in CMV-infected monocytes could potentially mitigate the indirect effects of CMV in transplantation. Additionally, the immunostimulatory properties of CMV immunoglobulin (CMVIG) on innate immune cells, including monocytes, may be harnessed to enhance anti-CMV immunity in transplant recipients [<xref rid="B109-viruses-16-01809" ref-type="bibr">109</xref>].</p></sec></sec><sec sec-type="conclusions" id="sec5-viruses-16-01809"><title>5. Conclusions</title><p>CMV infection has a profound impact on monocyte effector functions, impairing phagocytosis, antigen presentation, cytokine production, cell migration to sites of infection, and differentiation into effective immune cells. These alterations contribute to immune compromise and to susceptibility to infections, heightened inflammation, graft rejection, and long-term complications in immunocompromised individuals. Understanding the mechanisms by which CMV modulates monocyte functions is crucial for developing targeted therapies to mitigate the effects of CMV infection and improve clinical outcomes for affected patients.</p></sec></body><back><fn-group><fn><p><bold>Disclaimer/Publisher&#x02019;s Note:</bold> The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.</p></fn></fn-group><notes><title>Author Contributions</title><p>Conceptualization, M.S.P. and J.E.K.; investigation, M.S.P. and J.E.K.; resources, J.E.K.; writing&#x02014;original draft preparation, M.S.P. and J.E.K.; writing&#x02014;review and editing, M.S.P., J.A.F. and J.E.K.; visualization, J.E.K.; supervision, J.A.F. and J.E.K.; funding acquisition, J.A.F. and J.E.K. All authors have read and agreed to the published version of the manuscript.</p></notes><notes notes-type="COI-statement"><title>Conflicts of Interest</title><p>The authors declare no conflicts of interest. </p></notes><ref-list><title>References</title><ref id="B1-viruses-16-01809"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Min</surname><given-names>C.-K.</given-names></name>
<name><surname>Shakya</surname><given-names>A.K.</given-names></name>
<name><surname>Lee</surname><given-names>B.-J.</given-names></name>
<name><surname>Streblow</surname><given-names>D.N.</given-names></name>
<name><surname>Caposio</surname><given-names>P.</given-names></name>
<name><surname>Yurochko</surname><given-names>A.</given-names></name>
</person-group><article-title>The Differentiation of Human Cytomegalovirus Infected-Monocytes Is Required for Viral Replication</article-title><source>Front. Cell. Infeciton Microbiol.</source><year>2020</year><volume>10</volume><elocation-id>368</elocation-id><pub-id pub-id-type="doi">10.3389/fcimb.2020.00368</pub-id><pub-id pub-id-type="pmid">32850474</pub-id>
</element-citation></ref><ref id="B2-viruses-16-01809"><label>2.</label><element-citation publication-type="book"><person-group person-group-type="author">
<name><surname>Bruggeman</surname><given-names>C.A.</given-names></name>
</person-group><article-title>Cytomegalovirus and latency: An overview</article-title><source>Virchows Archiv B Cell Pathology Including Molecular Pathology</source><publisher-name>Springer Nature</publisher-name><publisher-loc>London, UK</publisher-loc><year>1993</year><volume>Volume 64</volume><fpage>325</fpage><lpage>333</lpage><pub-id pub-id-type="doi">10.1007/bf02915131</pub-id></element-citation></ref><ref id="B3-viruses-16-01809"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Forte</surname><given-names>E.</given-names></name>
<name><surname>Zhang</surname><given-names>Z.</given-names></name>
<name><surname>Thorp</surname><given-names>E.B.</given-names></name>
<name><surname>Hummel</surname><given-names>M.</given-names></name>
</person-group><article-title>Cytomegalovirus Latency and Reactivation: An Intricate Interplay With the Host Immune Response</article-title><source>Front. Cell. Infect. Microbiol.</source><year>2020</year><volume>10</volume><elocation-id>130</elocation-id><pub-id pub-id-type="doi">10.3389/fcimb.2020.00130</pub-id><pub-id pub-id-type="pmid">32296651</pub-id>
</element-citation></ref><ref id="B4-viruses-16-01809"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Jean Beltran</surname><given-names>P.M.</given-names></name>
<name><surname>Cristea</surname><given-names>I.M.</given-names></name>
</person-group><article-title>The life cycle and pathogenesis of human cytomegalovirus infection: Lessons from proteomics</article-title><source>Expert Rev. Proteom.</source><year>2014</year><volume>11</volume><fpage>697</fpage><lpage>711</lpage><pub-id pub-id-type="doi">10.1586/14789450.2014.971116</pub-id><pub-id pub-id-type="pmid">25327590</pub-id>
</element-citation></ref><ref id="B5-viruses-16-01809"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Fishman</surname><given-names>J.A.</given-names></name>
<name><surname>Rubin</surname><given-names>R.H.</given-names></name>
</person-group><article-title>Infection in organ-transplant recipients</article-title><source>N. Engl. J. Med.</source><year>1998</year><volume>338</volume><fpage>1741</fpage><lpage>1751</lpage><pub-id pub-id-type="doi">10.1056/NEJM199806113382407</pub-id><pub-id pub-id-type="pmid">9624195</pub-id>
</element-citation></ref><ref id="B6-viruses-16-01809"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Pesch</surname><given-names>M.H.</given-names></name>
<name><surname>Saunders</surname><given-names>N.A.</given-names></name>
<name><surname>Abdelnabi</surname><given-names>S.</given-names></name>
</person-group><article-title>Cytomegalovirus Infection in Pregnancy: Prevention, Presentation, Management and Neonatal Outcomes</article-title><source>J. Midwifery Women&#x02019;s Health</source><year>2021</year><volume>66</volume><fpage>397</fpage><lpage>402</lpage><pub-id pub-id-type="doi">10.1111/jmwh.13228</pub-id><pub-id pub-id-type="pmid">34031974</pub-id>
</element-citation></ref><ref id="B7-viruses-16-01809"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Taylor-Wiedeman</surname><given-names>J.</given-names></name>
<name><surname>Sissons</surname><given-names>J.G.P.</given-names></name>
<name><surname>Borysiewicz</surname><given-names>L.K.</given-names></name>
<name><surname>Sinclair</surname><given-names>J.H.</given-names></name>
</person-group><article-title>Monocytes are a major site of persistence of human cytomegalovirus in peripheral blood mononuclear cells</article-title><source>J. Gen. Virol.</source><year>1991</year><volume>72</volume><fpage>2059</fpage><lpage>2064</lpage><pub-id pub-id-type="doi">10.1099/0022-1317-72-9-2059</pub-id><pub-id pub-id-type="pmid">1654370</pub-id>
</element-citation></ref><ref id="B8-viruses-16-01809"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Ziegler-Heitbrock</surname><given-names>L.</given-names></name>
<name><surname>Ancuta</surname><given-names>P.</given-names></name>
<name><surname>Crowe</surname><given-names>S.</given-names></name>
<name><surname>Dalod</surname><given-names>M.</given-names></name>
<name><surname>Grau</surname><given-names>V.</given-names></name>
<name><surname>Hart</surname><given-names>D.N.</given-names></name>
<name><surname>Leenen</surname><given-names>P.J.M.</given-names></name>
<name><surname>Liu</surname><given-names>Y.-J.</given-names></name>
<name><surname>MacPherson</surname><given-names>G.</given-names></name>
<name><surname>Randolph</surname><given-names>G.J.</given-names></name>
<etal/>
</person-group><article-title>Nomenclature of monocytes and dendritic cells in blood</article-title><source>Blood</source><year>2010</year><volume>116</volume><fpage>e74</fpage><lpage>e80</lpage><pub-id pub-id-type="doi">10.1182/blood-2010-02-258558</pub-id><pub-id pub-id-type="pmid">20628149</pub-id>
</element-citation></ref><ref id="B9-viruses-16-01809"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Williams</surname><given-names>H.</given-names></name>
<name><surname>Mack</surname><given-names>C.</given-names></name>
<name><surname>Baraz</surname><given-names>R.</given-names></name>
<name><surname>Marimuthu</surname><given-names>R.</given-names></name>
<name><surname>Naralashetty</surname><given-names>S.</given-names></name>
<name><surname>Li</surname><given-names>S.</given-names></name>
<name><surname>Medbury</surname><given-names>H.</given-names></name>
</person-group><article-title>Monocyte Differentiation and Heterogeneity: Inter-Subset and Interindividual Differences</article-title><source>Int. J. Mol. Sci.</source><year>2023</year><volume>24</volume><elocation-id>8757</elocation-id><pub-id pub-id-type="doi">10.3390/ijms24108757</pub-id><pub-id pub-id-type="pmid">37240103</pub-id>
</element-citation></ref><ref id="B10-viruses-16-01809"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Sampath</surname><given-names>P.</given-names></name>
<name><surname>Moideen</surname><given-names>K.</given-names></name>
<name><surname>Ranganathan</surname><given-names>U.D.</given-names></name>
<name><surname>Bethunaickan</surname><given-names>R.</given-names></name>
</person-group><article-title>Monocyte Subsets: Phenotypes and Function in Tuberculosis Infection</article-title><source>Front. Immunol.</source><year>2018</year><volume>9</volume><elocation-id>1726</elocation-id><pub-id pub-id-type="doi">10.3389/fimmu.2018.01726</pub-id><pub-id pub-id-type="pmid">30105020</pub-id>
</element-citation></ref><ref id="B11-viruses-16-01809"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Villani</surname><given-names>A.C.</given-names></name>
<name><surname>Satija</surname><given-names>R.</given-names></name>
<name><surname>Reynolds</surname><given-names>G.</given-names></name>
<name><surname>Sarkizova</surname><given-names>S.</given-names></name>
<name><surname>Shekhar</surname><given-names>K.</given-names></name>
<name><surname>Fletcher</surname><given-names>J.</given-names></name>
<name><surname>Griesbeck</surname><given-names>M.</given-names></name>
<name><surname>Butler</surname><given-names>A.</given-names></name>
<name><surname>Zheng</surname><given-names>S.</given-names></name>
<name><surname>Lazo</surname><given-names>S.</given-names></name>
<etal/>
</person-group><article-title>Single-cell RNA-seq reveals new types of human blood dendritic cells, monocytes, and progenitors</article-title><source>Science</source><year>2017</year><volume>356</volume><fpage>eaah4573</fpage><pub-id pub-id-type="doi">10.1126/science.aah4573</pub-id><pub-id pub-id-type="pmid">28428369</pub-id>
</element-citation></ref><ref id="B12-viruses-16-01809"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Th&#x000e9;riault</surname><given-names>P.</given-names></name>
<name><surname>ElAli</surname><given-names>A.</given-names></name>
<name><surname>Rivest</surname><given-names>S.</given-names></name>
</person-group><article-title>The dynamics of monocytes and microglia in Alzheimer&#x02019;s disease</article-title><source>Alzheimer&#x02019;s Res. Ther.</source><year>2015</year><volume>7</volume><fpage>41</fpage><pub-id pub-id-type="doi">10.1186/s13195-015-0125-2</pub-id><pub-id pub-id-type="pmid">25878730</pub-id>
</element-citation></ref><ref id="B13-viruses-16-01809"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Carstensen</surname><given-names>M.</given-names></name>
<name><surname>Christensen</surname><given-names>T.</given-names></name>
<name><surname>Stilund</surname><given-names>M.</given-names></name>
<name><surname>M&#x000f8;ller</surname><given-names>H.J.</given-names></name>
<name><surname>Petersen</surname><given-names>E.L.</given-names></name>
<name><surname>Petersen</surname><given-names>T.</given-names></name>
</person-group><article-title>Activated monocytes and markers of inflammation in newly diagnosed multiple sclerosis</article-title><source>Immunol. Cell Biol.</source><year>2020</year><volume>98</volume><fpage>549</fpage><lpage>562</lpage><pub-id pub-id-type="doi">10.1111/imcb.12337</pub-id><pub-id pub-id-type="pmid">32253768</pub-id>
</element-citation></ref><ref id="B14-viruses-16-01809"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>El Khoury</surname><given-names>J.</given-names></name>
</person-group><article-title>Neurodegeneration and the neuroimmune system</article-title><source>Nat. Med.</source><year>2010</year><volume>16</volume><fpage>1369</fpage><lpage>1370</lpage><pub-id pub-id-type="doi">10.1038/nm1210-1369</pub-id><pub-id pub-id-type="pmid">21135838</pub-id>
</element-citation></ref><ref id="B15-viruses-16-01809"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Collins-McMillen</surname><given-names>D.</given-names></name>
<name><surname>Chesnokova</surname><given-names>L.</given-names></name>
<name><surname>Lee</surname><given-names>B.-J.</given-names></name>
<name><surname>Fulkerson</surname><given-names>H.L.</given-names></name>
<name><surname>Brooks</surname><given-names>R.</given-names></name>
<name><surname>Mosher</surname><given-names>B.S.</given-names></name>
<name><surname>Yurochko</surname><given-names>A.D.</given-names></name>
</person-group><article-title>HCMV Infection and Apoptosis: How Do Monocytes Survive HCMV Infection?</article-title><source>Viruses</source><year>2018</year><volume>10</volume><elocation-id>533</elocation-id><pub-id pub-id-type="doi">10.3390/v10100533</pub-id><pub-id pub-id-type="pmid">30274264</pub-id>
</element-citation></ref><ref id="B16-viruses-16-01809"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Ley</surname><given-names>K.</given-names></name>
</person-group><article-title>M1 Means Kill; M2 Means Heal</article-title><source>J. Immunol.</source><year>2017</year><volume>199</volume><fpage>2191</fpage><lpage>2193</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.1701135</pub-id><pub-id pub-id-type="pmid">28923980</pub-id>
</element-citation></ref><ref id="B17-viruses-16-01809"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Murray</surname><given-names>P.J.</given-names></name>
<name><surname>Allen</surname><given-names>J.E.</given-names></name>
<name><surname>Biswas</surname><given-names>S.K.</given-names></name>
<name><surname>Fisher</surname><given-names>E.A.</given-names></name>
<name><surname>Gilroy</surname><given-names>D.W.</given-names></name>
<name><surname>Goerdt</surname><given-names>S.</given-names></name>
<name><surname>Gordon</surname><given-names>S.</given-names></name>
<name><surname>Hamilton</surname><given-names>J.A.</given-names></name>
<name><surname>Ivashkiv</surname><given-names>L.B.</given-names></name>
<name><surname>Lawrence</surname><given-names>T.</given-names></name>
<etal/>
</person-group><article-title>Macrophage activation and polarization: Nomenclature and experimental guidelines</article-title><source>Immunity</source><year>2014</year><volume>41</volume><fpage>14</fpage><lpage>20</lpage><pub-id pub-id-type="doi">10.1016/j.immuni.2014.06.008</pub-id><pub-id pub-id-type="pmid">25035950</pub-id>
</element-citation></ref><ref id="B18-viruses-16-01809"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Miko&#x00142;ajczyk</surname><given-names>T.P.</given-names></name>
<name><surname>Skrzeczy&#x00144;ska-Moncznik</surname><given-names>J.E.</given-names></name>
<name><surname>Zar&#x00119;bski</surname><given-names>M.A.</given-names></name>
<name><surname>Marewicz</surname><given-names>E.A.</given-names></name>
<name><surname>Wi&#x0015b;niewska</surname><given-names>A.M.</given-names></name>
<name><surname>Dzi&#x00119;ba</surname><given-names>M.</given-names></name>
<name><surname>Dobrucki</surname><given-names>J.W.</given-names></name>
<name><surname>Pryjma</surname><given-names>J.R.</given-names></name>
</person-group><article-title>Interaction of human peripheral blood monocytes with apoptotic polymorphonuclear cells</article-title><source>Immunology</source><year>2009</year><volume>128</volume><fpage>103</fpage><lpage>113</lpage><pub-id pub-id-type="doi">10.1111/j.1365-2567.2009.03087.x</pub-id><pub-id pub-id-type="pmid">19689740</pub-id>
</element-citation></ref><ref id="B19-viruses-16-01809"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Serbina</surname><given-names>N.V.</given-names></name>
<name><surname>Jia</surname><given-names>T.</given-names></name>
<name><surname>Hohl</surname><given-names>T.M.</given-names></name>
<name><surname>Pamer</surname><given-names>E.G.</given-names></name>
</person-group><article-title>Monocyte-mediated defense against microbial pathogens</article-title><source>Annu. Rev. Immunol.</source><year>2008</year><volume>26</volume><fpage>421</fpage><lpage>452</lpage><pub-id pub-id-type="doi">10.1146/annurev.immunol.26.021607.090326</pub-id><pub-id pub-id-type="pmid">18303997</pub-id>
</element-citation></ref><ref id="B20-viruses-16-01809"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Westman</surname><given-names>J.</given-names></name>
<name><surname>Grinstein</surname><given-names>S.</given-names></name>
<name><surname>Marques</surname><given-names>P.E.</given-names></name>
</person-group><article-title>Phagocytosis of Necrotic Debris at Sites of Injury and Inflammation</article-title><source>Front. Immunol.</source><year>2019</year><volume>10</volume><elocation-id>3030</elocation-id><pub-id pub-id-type="doi">10.3389/fimmu.2019.03030</pub-id><pub-id pub-id-type="pmid">31998312</pub-id>
</element-citation></ref><ref id="B21-viruses-16-01809"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Alquraini</surname><given-names>A.</given-names></name>
<name><surname>El Khoury</surname><given-names>J.</given-names></name>
</person-group><article-title>Scavenger receptors</article-title><source>Curr. Biol.</source><year>2020</year><volume>30</volume><fpage>R790</fpage><lpage>R795</lpage><pub-id pub-id-type="doi">10.1016/j.cub.2020.05.051</pub-id><pub-id pub-id-type="pmid">32693066</pub-id>
</element-citation></ref><ref id="B22-viruses-16-01809"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Wicherska-Paw&#x00142;owska</surname><given-names>K.</given-names></name>
<name><surname>Wr&#x000f3;bel</surname><given-names>T.</given-names></name>
<name><surname>Rybka</surname><given-names>J.</given-names></name>
</person-group><article-title>Toll-Like Receptors (TLRs), NOD-Like Receptors (NLRs), and RIG-I-Like Receptors (RLRs) in Innate Immunity. TLRs, NLRs, and RLRs Ligands as Immunotherapeutic Agents for Hematopoietic Diseases</article-title><source>Int. J. Mol. Sci.</source><year>2021</year><volume>22</volume><elocation-id>13397</elocation-id><pub-id pub-id-type="doi">10.3390/ijms222413397</pub-id><pub-id pub-id-type="pmid">34948194</pub-id>
</element-citation></ref><ref id="B23-viruses-16-01809"><label>23.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Nimmerjahn</surname><given-names>F.</given-names></name>
<name><surname>Ravetch</surname><given-names>J.V.</given-names></name>
</person-group><article-title>Fcgamma receptors as regulators of immune responses</article-title><source>Nat. Rev. Immunol.</source><year>2008</year><volume>8</volume><fpage>34</fpage><lpage>47</lpage><pub-id pub-id-type="doi">10.1038/nri2206</pub-id><pub-id pub-id-type="pmid">18064051</pub-id>
</element-citation></ref><ref id="B24-viruses-16-01809"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Vandendriessche</surname><given-names>S.</given-names></name>
<name><surname>Cambier</surname><given-names>S.</given-names></name>
<name><surname>Proost</surname><given-names>P.</given-names></name>
<name><surname>Marques</surname><given-names>P.E.</given-names></name>
</person-group><article-title>Complement Receptors and Their Role in Leukocyte Recruitment and Phagocytosis</article-title><source>Front. Cell Dev. Biol.</source><year>2021</year><volume>9</volume><elocation-id>624025</elocation-id><pub-id pub-id-type="doi">10.3389/fcell.2021.624025</pub-id><pub-id pub-id-type="pmid">33644062</pub-id>
</element-citation></ref><ref id="B25-viruses-16-01809"><label>25.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Uribe-Querol</surname><given-names>E.</given-names></name>
<name><surname>Rosales</surname><given-names>C.</given-names></name>
</person-group><article-title>Phagocytosis: Our Current Understanding of a Universal Biological Process</article-title><source>Front. Immunol.</source><year>2020</year><volume>11</volume><elocation-id>1066</elocation-id><pub-id pub-id-type="doi">10.3389/fimmu.2020.01066</pub-id><pub-id pub-id-type="pmid">32582172</pub-id>
</element-citation></ref><ref id="B26-viruses-16-01809"><label>26.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Lauvau</surname><given-names>G.</given-names></name>
<name><surname>Chorro</surname><given-names>L.</given-names></name>
<name><surname>Spaulding</surname><given-names>E.</given-names></name>
<name><surname>Soudja</surname><given-names>S.M.</given-names></name>
</person-group><article-title>Inflammatory monocyte effector mechanisms</article-title><source>Cell. Immunol.</source><year>2014</year><volume>291</volume><fpage>32</fpage><lpage>40</lpage><pub-id pub-id-type="doi">10.1016/j.cellimm.2014.07.007</pub-id><pub-id pub-id-type="pmid">25205002</pub-id>
</element-citation></ref><ref id="B27-viruses-16-01809"><label>27.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Larson</surname><given-names>S.R.</given-names></name>
<name><surname>Atif</surname><given-names>S.M.</given-names></name>
<name><surname>Gibbings</surname><given-names>S.L.</given-names></name>
<name><surname>Thomas</surname><given-names>S.M.</given-names></name>
<name><surname>Prabagar</surname><given-names>M.G.</given-names></name>
<name><surname>Danhorn</surname><given-names>T.</given-names></name>
<name><surname>Leach</surname><given-names>S.M.</given-names></name>
<name><surname>Henson</surname><given-names>P.M.</given-names></name>
<name><surname>Jakubzick</surname><given-names>C.V.</given-names></name>
</person-group><article-title>Ly6C<sup>+</sup> monocyte efferocytosis and cross-presentation of cell-associated antigens</article-title><source>Cell Death Differ.</source><year>2016</year><volume>23</volume><fpage>997</fpage><lpage>1003</lpage><pub-id pub-id-type="doi">10.1038/cdd.2016.24</pub-id><pub-id pub-id-type="pmid">26990659</pub-id>
</element-citation></ref><ref id="B28-viruses-16-01809"><label>28.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Huang</surname><given-names>M.-N.</given-names></name>
<name><surname>Nicholson</surname><given-names>L.T.</given-names></name>
<name><surname>Batich</surname><given-names>K.A.</given-names></name>
<name><surname>Swartz</surname><given-names>A.M.</given-names></name>
<name><surname>Kopin</surname><given-names>D.</given-names></name>
<name><surname>Wellford</surname><given-names>S.</given-names></name>
<name><surname>Prabhakar</surname><given-names>V.K.</given-names></name>
<name><surname>Woroniecka</surname><given-names>K.</given-names></name>
<name><surname>Nair</surname><given-names>S.K.</given-names></name>
<name><surname>Fecci</surname><given-names>P.E.</given-names></name>
<etal/>
</person-group><article-title>Antigen-loaded monocyte administration induces potent therapeutic antitumor T cell responses</article-title><source>J. Clin. Investig.</source><year>2020</year><volume>130</volume><fpage>774</fpage><lpage>788</lpage><pub-id pub-id-type="doi">10.1172/JCI128267</pub-id><pub-id pub-id-type="pmid">31661470</pub-id>
</element-citation></ref><ref id="B29-viruses-16-01809"><label>29.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Schlitzer</surname><given-names>A.</given-names></name>
<name><surname>Zhang</surname><given-names>W.</given-names></name>
<name><surname>Song</surname><given-names>M.</given-names></name>
<name><surname>Ma</surname><given-names>X.</given-names></name>
</person-group><article-title>Recent advances in understanding dendritic cell development, classification, and phenotype</article-title><source>F1000Research</source><year>2018</year><volume>7</volume><fpage>1558</fpage><pub-id pub-id-type="doi">10.12688/f1000research.14793.1</pub-id></element-citation></ref><ref id="B30-viruses-16-01809"><label>30.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Muntjewerff</surname><given-names>E.M.</given-names></name>
<name><surname>Meesters</surname><given-names>L.D.</given-names></name>
<name><surname>van den Bogaart</surname><given-names>G.</given-names></name>
</person-group><article-title>Antigen Cross-Presentation by Macrophages</article-title><source>Front. Immunol.</source><year>2020</year><volume>11</volume><elocation-id>1276</elocation-id><pub-id pub-id-type="doi">10.3389/fimmu.2020.01276</pub-id><pub-id pub-id-type="pmid">32733446</pub-id>
</element-citation></ref><ref id="B31-viruses-16-01809"><label>31.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Kany</surname><given-names>S.</given-names></name>
<name><surname>Vollrath</surname><given-names>J.T.</given-names></name>
<name><surname>Relja</surname><given-names>B.</given-names></name>
</person-group><article-title>Cytokines in Inflammatory Disease</article-title><source>Int. J. Mol. Sci.</source><year>2019</year><volume>20</volume><elocation-id>6008</elocation-id><pub-id pub-id-type="doi">10.3390/ijms20236008</pub-id><pub-id pub-id-type="pmid">31795299</pub-id>
</element-citation></ref><ref id="B32-viruses-16-01809"><label>32.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Choi</surname><given-names>B.-R.</given-names></name>
<name><surname>Johnson</surname><given-names>K.R.</given-names></name>
<name><surname>Maric</surname><given-names>D.</given-names></name>
<name><surname>McGavern</surname><given-names>D.B.</given-names></name>
</person-group><article-title>Monocyte-derived IL-6 programs microglia to rebuild damaged brain vasculature</article-title><source>Nat. Immunol.</source><year>2023</year><volume>24</volume><fpage>1110</fpage><lpage>1123</lpage><pub-id pub-id-type="doi">10.1038/s41590-023-01521-1</pub-id><pub-id pub-id-type="pmid">37248420</pub-id>
</element-citation></ref><ref id="B33-viruses-16-01809"><label>33.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Crane</surname><given-names>M.J.</given-names></name>
<name><surname>Hokeness-Antonelli</surname><given-names>K.L.</given-names></name>
<name><surname>Salazar-Mather</surname><given-names>T.P.</given-names></name>
</person-group><article-title>Regulation of inflammatory monocyte/macrophage recruitment from the bone marrow during murine cytomegalovirus infection: Role for type I interferons in localized induction of CCR2 ligands</article-title><source>J. Immunol.</source><year>2009</year><volume>183</volume><fpage>2810</fpage><lpage>2817</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.0900205</pub-id><pub-id pub-id-type="pmid">19620305</pub-id>
</element-citation></ref><ref id="B34-viruses-16-01809"><label>34.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Ozga</surname><given-names>A.J.</given-names></name>
<name><surname>Chow</surname><given-names>M.T.</given-names></name>
<name><surname>Luster</surname><given-names>A.D.</given-names></name>
</person-group><article-title>Chemokines and the immune response to cancer</article-title><source>Immunity</source><year>2021</year><volume>54</volume><fpage>859</fpage><lpage>874</lpage><pub-id pub-id-type="doi">10.1016/j.immuni.2021.01.012</pub-id><pub-id pub-id-type="pmid">33838745</pub-id>
</element-citation></ref><ref id="B35-viruses-16-01809"><label>35.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Karki</surname><given-names>R.</given-names></name>
<name><surname>Kanneganti</surname><given-names>T.D.</given-names></name>
</person-group><article-title>The &#x02018;cytokine storm&#x02019;: Molecular mechanisms and therapeutic prospects</article-title><source>Trends Immunol.</source><year>2021</year><volume>42</volume><fpage>681</fpage><lpage>705</lpage><pub-id pub-id-type="doi">10.1016/j.it.2021.06.001</pub-id><pub-id pub-id-type="pmid">34217595</pub-id>
</element-citation></ref><ref id="B36-viruses-16-01809"><label>36.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Deshmane</surname><given-names>S.L.</given-names></name>
<name><surname>Kremlev</surname><given-names>S.</given-names></name>
<name><surname>Amini</surname><given-names>S.</given-names></name>
<name><surname>Sawaya</surname><given-names>B.E.</given-names></name>
</person-group><article-title>Monocyte chemoattractant protein-1 (MCP-1): An overview</article-title><source>J. Interf. Cytokine Res.</source><year>2009</year><volume>29</volume><fpage>313</fpage><lpage>326</lpage><pub-id pub-id-type="doi">10.1089/jir.2008.0027</pub-id><pub-id pub-id-type="pmid">19441883</pub-id>
</element-citation></ref><ref id="B37-viruses-16-01809"><label>37.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Sokol</surname><given-names>C.L.</given-names></name>
<name><surname>Luster</surname><given-names>A.D.</given-names></name>
</person-group><article-title>The chemokine system in innate immunity</article-title><source>Cold Spring Harb. Perspect. Biol.</source><year>2015</year><volume>7</volume><elocation-id>a016303</elocation-id><pub-id pub-id-type="doi">10.1101/cshperspect.a016303</pub-id><pub-id pub-id-type="pmid">25635046</pub-id>
</element-citation></ref><ref id="B38-viruses-16-01809"><label>38.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Heit</surname><given-names>B.</given-names></name>
<name><surname>Tavener</surname><given-names>S.</given-names></name>
<name><surname>Raharjo</surname><given-names>E.</given-names></name>
<name><surname>Kubes</surname><given-names>P.</given-names></name>
</person-group><article-title>An intracellular signaling hierarchy determines direction of migration in opposing chemotactic gradients</article-title><source>J. Cell Biol.</source><year>2002</year><volume>159</volume><fpage>91</fpage><lpage>102</lpage><pub-id pub-id-type="doi">10.1083/jcb.200202114</pub-id><pub-id pub-id-type="pmid">12370241</pub-id>
</element-citation></ref><ref id="B39-viruses-16-01809"><label>39.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Smith</surname><given-names>P.D.</given-names></name>
<name><surname>Ohura</surname><given-names>K.</given-names></name>
<name><surname>Masur</surname><given-names>H.</given-names></name>
<name><surname>Lane</surname><given-names>H.C.</given-names></name>
<name><surname>Fauci</surname><given-names>A.S.</given-names></name>
<name><surname>Wahl</surname><given-names>S.M.</given-names></name>
</person-group><article-title>Wahl, Monocyte function in the acquired immune deficiency syndrome. Defective chemotaxis</article-title><source>J. Clin. Investig.</source><year>1984</year><volume>74</volume><fpage>2121</fpage><lpage>2128</lpage><pub-id pub-id-type="doi">10.1172/JCI111637</pub-id><pub-id pub-id-type="pmid">6511917</pub-id>
</element-citation></ref><ref id="B40-viruses-16-01809"><label>40.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>El Khoury</surname><given-names>J.</given-names></name>
<name><surname>Toft</surname><given-names>M.</given-names></name>
<name><surname>Hickman</surname><given-names>S.E.</given-names></name>
<name><surname>Means</surname><given-names>T.K.</given-names></name>
<name><surname>Terada</surname><given-names>K.</given-names></name>
<name><surname>Geula</surname><given-names>C.</given-names></name>
<name><surname>Luster</surname><given-names>A.D.</given-names></name>
</person-group><article-title>Ccr2 deficiency impairs microglial accumulation and accelerates progression of Alzheimer-like disease</article-title><source>Nat. Med.</source><year>2007</year><volume>13</volume><fpage>432</fpage><lpage>438</lpage><pub-id pub-id-type="doi">10.1038/nm1555</pub-id><pub-id pub-id-type="pmid">17351623</pub-id>
</element-citation></ref><ref id="B41-viruses-16-01809"><label>41.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Hickman</surname><given-names>S.E.</given-names></name>
<name><surname>Allison</surname><given-names>E.K.</given-names></name>
<name><surname>Coleman</surname><given-names>U.</given-names></name>
<name><surname>Kingery-Gallagher</surname><given-names>N.D.</given-names></name>
<name><surname>El Khoury</surname><given-names>J.</given-names></name>
</person-group><article-title>Heterozygous CX3CR1 Deficiency in Microglia Restores Neuronal beta-Amyloid Clearance Pathways and Slows Progression of Alzheimer&#x02032;s Like-Disease in PS1-APP Mice</article-title><source>Front. Immunol.</source><year>2019</year><volume>10</volume><elocation-id>2780</elocation-id><pub-id pub-id-type="doi">10.3389/fimmu.2019.02780</pub-id><pub-id pub-id-type="pmid">31849963</pub-id>
</element-citation></ref><ref id="B42-viruses-16-01809"><label>42.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Kratofil</surname><given-names>R.M.</given-names></name>
<name><surname>Kubes</surname><given-names>P.</given-names></name>
<name><surname>Deniset</surname><given-names>J.F.</given-names></name>
</person-group><article-title>Monocyte Conversion During Inflammation and Injury</article-title><source>Arter. Thromb. Vasc. Biol.</source><year>2017</year><volume>37</volume><fpage>35</fpage><lpage>42</lpage><pub-id pub-id-type="doi">10.1161/ATVBAHA.116.308198</pub-id><pub-id pub-id-type="pmid">27765768</pub-id>
</element-citation></ref><ref id="B43-viruses-16-01809"><label>43.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Das</surname><given-names>A.</given-names></name>
<name><surname>Sinha</surname><given-names>M.</given-names></name>
<name><surname>Datta</surname><given-names>S.</given-names></name>
<name><surname>Abas</surname><given-names>M.</given-names></name>
<name><surname>Chaffee</surname><given-names>S.</given-names></name>
<name><surname>Sen</surname><given-names>C.K.</given-names></name>
<name><surname>Roy</surname><given-names>S.</given-names></name>
</person-group><article-title>Monocyte and macrophage plasticity in tissue repair and regeneration</article-title><source>Am. J. Pathol.</source><year>2015</year><volume>185</volume><fpage>2596</fpage><lpage>2606</lpage><pub-id pub-id-type="doi">10.1016/j.ajpath.2015.06.001</pub-id><pub-id pub-id-type="pmid">26118749</pub-id>
</element-citation></ref><ref id="B44-viruses-16-01809"><label>44.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Italiani</surname><given-names>P.</given-names></name>
<name><surname>Boraschi</surname><given-names>D.</given-names></name>
</person-group><article-title>From Monocytes to M1/M2 Macrophages: Phenotypical vs. Functional Differentiation</article-title><source>Front. Immunol.</source><year>2014</year><volume>5</volume><elocation-id>514</elocation-id><pub-id pub-id-type="doi">10.3389/fimmu.2014.00514</pub-id><pub-id pub-id-type="pmid">25368618</pub-id>
</element-citation></ref><ref id="B45-viruses-16-01809"><label>45.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Weiss</surname><given-names>S.J.</given-names></name>
<name><surname>King</surname><given-names>G.W.</given-names></name>
<name><surname>LoBuglio</surname><given-names>A.F.</given-names></name>
</person-group><article-title>Evidence for hydroxyl radical generation by human Monocytes</article-title><source>J. Clin. Investig.</source><year>1977</year><volume>60</volume><fpage>370</fpage><lpage>373</lpage><pub-id pub-id-type="doi">10.1172/JCI108785</pub-id><pub-id pub-id-type="pmid">194926</pub-id>
</element-citation></ref><ref id="B46-viruses-16-01809"><label>46.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Johnston</surname><given-names>R.B.</given-names></name>
<name><surname>Kitagawa</surname><given-names>S.</given-names></name>
</person-group><article-title>Molecular basis for the enhanced respiratory burst of activated macrophages</article-title><source>Fed. Proc.</source><year>1985</year><volume>44</volume><fpage>2927</fpage><lpage>2932</lpage><pub-id pub-id-type="pmid">2996947</pub-id>
</element-citation></ref><ref id="B47-viruses-16-01809"><label>47.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Canton</surname><given-names>M.</given-names></name>
<name><surname>S&#x000e1;nchez-Rodr&#x000ed;guez</surname><given-names>R.</given-names></name>
<name><surname>Spera</surname><given-names>I.</given-names></name>
<name><surname>Venegas</surname><given-names>F.C.</given-names></name>
<name><surname>Favia</surname><given-names>M.</given-names></name>
<name><surname>Viola</surname><given-names>A.</given-names></name>
<name><surname>Castegna</surname><given-names>A.</given-names></name>
</person-group><article-title>Reactive Oxygen Species in Macrophages: Sources and Targets</article-title><source>Front. Immunol.</source><year>2021</year><volume>12</volume><elocation-id>734229</elocation-id><pub-id pub-id-type="doi">10.3389/fimmu.2021.734229</pub-id><pub-id pub-id-type="pmid">34659222</pub-id>
</element-citation></ref><ref id="B48-viruses-16-01809"><label>48.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Tan</surname><given-names>H.-Y.</given-names></name>
<name><surname>Wang</surname><given-names>N.</given-names></name>
<name><surname>Li</surname><given-names>S.</given-names></name>
<name><surname>Hong</surname><given-names>M.</given-names></name>
<name><surname>Wang</surname><given-names>X.</given-names></name>
<name><surname>Feng</surname><given-names>Y.</given-names></name>
</person-group><article-title>The Reactive Oxygen Species in Macrophage Polarization: Reflecting Its Dual Role in Progression and Treatment of Human Diseases</article-title><source>Oxidative Med. Cell. Longev.</source><year>2016</year><volume>2016</volume><fpage>2795090</fpage><pub-id pub-id-type="doi">10.1155/2016/2795090</pub-id></element-citation></ref><ref id="B49-viruses-16-01809"><label>49.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Viola</surname><given-names>A.</given-names></name>
<name><surname>Munari</surname><given-names>F.</given-names></name>
<name><surname>S&#x000e1;nchez-Rodr&#x000ed;guez</surname><given-names>R.</given-names></name>
<name><surname>Scolaro</surname><given-names>T.</given-names></name>
<name><surname>Castegna</surname><given-names>A.</given-names></name>
</person-group><article-title>The Metabolic Signature of Macrophage Responses</article-title><source>Front. Immunol.</source><year>2019</year><volume>10</volume><elocation-id>1462</elocation-id><pub-id pub-id-type="doi">10.3389/fimmu.2019.01462</pub-id><pub-id pub-id-type="pmid">31333642</pub-id>
</element-citation></ref><ref id="B50-viruses-16-01809"><label>50.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Puntarulo</surname><given-names>S.</given-names></name>
<name><surname>Galleano</surname><given-names>M.</given-names></name>
<name><surname>Sanchez</surname><given-names>R.</given-names></name>
<name><surname>Boveris</surname><given-names>A.</given-names></name>
</person-group><article-title>Superoxide anion and hydrogen peroxide metabolism in soybean embryonic axes during germination</article-title><source>Biochim. Biophys. Acta</source><year>1991</year><volume>1074</volume><fpage>277</fpage><lpage>283</lpage><pub-id pub-id-type="doi">10.1016/0304-4165(91)90164-C</pub-id><pub-id pub-id-type="pmid">1648400</pub-id>
</element-citation></ref><ref id="B51-viruses-16-01809"><label>51.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Hazen</surname><given-names>S.L.</given-names></name>
<name><surname>Zhang</surname><given-names>R.</given-names></name>
<name><surname>Shen</surname><given-names>Z.</given-names></name>
<name><surname>Wu</surname><given-names>W.</given-names></name>
<name><surname>Podrez</surname><given-names>E.A.</given-names></name>
<name><surname>MacPherson</surname><given-names>J.C.</given-names></name>
<name><surname>Schmitt</surname><given-names>D.</given-names></name>
<name><surname>Mitra</surname><given-names>S.N.</given-names></name>
<name><surname>Mukhopadhyay</surname><given-names>C.</given-names></name>
<name><surname>Chen</surname><given-names>Y.</given-names></name>
<etal/>
</person-group><article-title>Formation of nitric oxide-derived oxidants by myeloperoxidase in monocytes: Pathways for monocyte-mediated protein nitration and lipid peroxidation In vivo</article-title><source>Circ. Res.</source><year>1999</year><volume>85</volume><fpage>950</fpage><lpage>958</lpage><pub-id pub-id-type="doi">10.1161/01.RES.85.10.950</pub-id><pub-id pub-id-type="pmid">10559142</pub-id>
</element-citation></ref><ref id="B52-viruses-16-01809"><label>52.</label><element-citation publication-type="book"><person-group person-group-type="author">
<name><surname>Crow</surname><given-names>J.P.</given-names></name>
<name><surname>Beckman</surname><given-names>J.S.</given-names></name>
</person-group><article-title>The role of peroxynitrite in nitric oxide-mediated toxicity</article-title><source>The Role of Nitric Oxide in Physiology and Pathophysiology</source><publisher-name>Springer</publisher-name><publisher-loc>Berlin/Heidelberg, Germany</publisher-loc><year>1995</year><volume>Volume 196</volume><fpage>57</fpage><lpage>73</lpage><pub-id pub-id-type="doi">10.1007/978-3-642-79130-7_7</pub-id><pub-id pub-id-type="pmid">7634825</pub-id>
</element-citation></ref><ref id="B53-viruses-16-01809"><label>53.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Lennicke</surname><given-names>C.</given-names></name>
<name><surname>Cochem&#x000e9;</surname><given-names>H.M.</given-names></name>
</person-group><article-title>Redox metabolism: ROS as specific molecular regulators of cell signaling and function</article-title><source>Mol. Cell</source><year>2021</year><volume>81</volume><fpage>3691</fpage><lpage>3707</lpage><pub-id pub-id-type="doi">10.1016/j.molcel.2021.08.018</pub-id><pub-id pub-id-type="pmid">34547234</pub-id>
</element-citation></ref><ref id="B54-viruses-16-01809"><label>54.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Batty</surname><given-names>M.</given-names></name>
<name><surname>Bennett</surname><given-names>M.R.</given-names></name>
<name><surname>Yu</surname><given-names>E.</given-names></name>
</person-group><article-title>The Role of Oxidative Stress in Atherosclerosis</article-title><source>Cells</source><year>2022</year><volume>11</volume><elocation-id>3843</elocation-id><pub-id pub-id-type="doi">10.3390/cells11233843</pub-id><pub-id pub-id-type="pmid">36497101</pub-id>
</element-citation></ref><ref id="B55-viruses-16-01809"><label>55.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Wang</surname><given-names>X.</given-names></name>
<name><surname>Fan</surname><given-names>D.</given-names></name>
<name><surname>Cao</surname><given-names>X.</given-names></name>
<name><surname>Ye</surname><given-names>Q.</given-names></name>
<name><surname>Wang</surname><given-names>Q.</given-names></name>
<name><surname>Zhang</surname><given-names>M.</given-names></name>
<name><surname>Xiao</surname><given-names>C.</given-names></name>
</person-group><article-title>The Role of Reactive Oxygen Species in the Rheumatoid Arthritis-Associated Synovial Microenvironment</article-title><source>Antioxidants</source><year>2022</year><volume>11</volume><elocation-id>1153</elocation-id><pub-id pub-id-type="doi">10.3390/antiox11061153</pub-id><pub-id pub-id-type="pmid">35740050</pub-id>
</element-citation></ref><ref id="B56-viruses-16-01809"><label>56.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Leung</surname><given-names>E.</given-names></name>
<name><surname>Guo</surname><given-names>L.</given-names></name>
<name><surname>Bu</surname><given-names>J.</given-names></name>
<name><surname>Maloof</surname><given-names>M.</given-names></name>
<name><surname>El Khoury</surname><given-names>J.</given-names></name>
<name><surname>Geula</surname><given-names>C.</given-names></name>
</person-group><article-title>Microglia activation mediates fibrillar amyloid-beta toxicity in the aged primate cortex</article-title><source>Neurobiol. Aging</source><year>2011</year><volume>32</volume><fpage>387</fpage><lpage>397</lpage><pub-id pub-id-type="doi">10.1016/j.neurobiolaging.2009.02.025</pub-id><pub-id pub-id-type="pmid">19349094</pub-id>
</element-citation></ref><ref id="B57-viruses-16-01809"><label>57.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Jensen</surname><given-names>I.J.</given-names></name>
<name><surname>McGonagill</surname><given-names>P.W.</given-names></name>
<name><surname>Berton</surname><given-names>R.R.</given-names></name>
<name><surname>Wagner</surname><given-names>B.A.</given-names></name>
<name><surname>Silva</surname><given-names>E.E.</given-names></name>
<name><surname>Buettner</surname><given-names>G.R.</given-names></name>
<name><surname>Griffith</surname><given-names>T.S.</given-names></name>
<name><surname>Badovinac</surname><given-names>V.P.</given-names></name>
</person-group><article-title>Prolonged Reactive Oxygen Species Production following Septic Insult</article-title><source>ImmunoHorizons</source><year>2021</year><volume>5</volume><fpage>477</fpage><lpage>488</lpage><pub-id pub-id-type="doi">10.4049/immunohorizons.2100027</pub-id><pub-id pub-id-type="pmid">34145054</pub-id>
</element-citation></ref><ref id="B58-viruses-16-01809"><label>58.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Nogalski</surname><given-names>M.T.</given-names></name>
<name><surname>Chan</surname><given-names>G.C.T.</given-names></name>
<name><surname>Stevenson</surname><given-names>E.V.</given-names></name>
<name><surname>Collins-McMillen</surname><given-names>D.K.</given-names></name>
<name><surname>Yurochko</surname><given-names>A.D.</given-names></name>
</person-group><article-title>The HCMV gH/gL/UL128-131 complex triggers the specific cellular activation required for efficient viral internalization into target monocytes</article-title><source>PLoS Pathog.</source><year>2013</year><volume>9</volume><elocation-id>e1003463</elocation-id><pub-id pub-id-type="doi">10.1371/journal.ppat.1003463</pub-id><pub-id pub-id-type="pmid">23853586</pub-id>
</element-citation></ref><ref id="B59-viruses-16-01809"><label>59.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Chan</surname><given-names>G.</given-names></name>
<name><surname>Nogalski</surname><given-names>M.T.</given-names></name>
<name><surname>Yurochko</surname><given-names>A.D.</given-names></name>
</person-group><article-title>Activation of EGFR on monocytes is required for human cytomegalovirus entry and mediates cellular motility</article-title><source>Proc. Natl. Acad. Sci. USA</source><year>2009</year><volume>106</volume><fpage>22369</fpage><lpage>22374</lpage><pub-id pub-id-type="doi">10.1073/pnas.0908787106</pub-id><pub-id pub-id-type="pmid">20018733</pub-id>
</element-citation></ref><ref id="B60-viruses-16-01809"><label>60.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Nogalski</surname><given-names>M.T.</given-names></name>
<name><surname>Chan</surname><given-names>G.</given-names></name>
<name><surname>Stevenson</surname><given-names>E.V.</given-names></name>
<name><surname>Gray</surname><given-names>S.</given-names></name>
<name><surname>Yurochko</surname><given-names>A.D.</given-names></name>
</person-group><article-title>Human cytomegalovirus-regulated paxillin in monocytes links cellular pathogenic motility to the process of viral entry</article-title><source>J. Virol.</source><year>2011</year><volume>85</volume><fpage>1360</fpage><lpage>1369</lpage><pub-id pub-id-type="doi">10.1128/JVI.02090-10</pub-id><pub-id pub-id-type="pmid">21084488</pub-id>
</element-citation></ref><ref id="B61-viruses-16-01809"><label>61.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Sen</surname><given-names>P.</given-names></name>
<name><surname>Wilkie</surname><given-names>A.R.</given-names></name>
<name><surname>Ji</surname><given-names>F.</given-names></name>
<name><surname>Yang</surname><given-names>Y.</given-names></name>
<name><surname>Taylor</surname><given-names>I.J.</given-names></name>
<name><surname>Velazquez-Palafox</surname><given-names>M.</given-names></name>
<name><surname>Vanni</surname><given-names>E.A.H.</given-names></name>
<name><surname>Pesola</surname><given-names>J.M.</given-names></name>
<name><surname>Fernandez</surname><given-names>R.</given-names></name>
<name><surname>Chen</surname><given-names>H.</given-names></name>
<etal/>
</person-group><article-title>Linking indirect effects of cytomegalovirus in transplantation to modulation of monocyte innate immune function</article-title><source>Sci. Adv.</source><year>2020</year><volume>6</volume><fpage>eaax9856</fpage><pub-id pub-id-type="doi">10.1126/sciadv.aax9856</pub-id><pub-id pub-id-type="pmid">32494628</pub-id>
</element-citation></ref><ref id="B62-viruses-16-01809"><label>62.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Dropulic</surname><given-names>L.K.</given-names></name>
<name><surname>Lederman</surname><given-names>H.M.</given-names></name>
</person-group><article-title>Overview of Infections in the Immunocompromised Host</article-title><source>Microbiol. Spectr.</source><year>2016</year><volume>4</volume><fpage>3</fpage><lpage>50</lpage><pub-id pub-id-type="doi">10.1128/microbiolspec.DMIH2-0026-2016</pub-id><pub-id pub-id-type="pmid">27726779</pub-id>
</element-citation></ref><ref id="B63-viruses-16-01809"><label>63.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Imlay</surname><given-names>H.</given-names></name>
<name><surname>Limaye</surname><given-names>A.P.</given-names></name>
</person-group><article-title>Current Understanding of Cytomegalovirus Reactivation in Critical Illness</article-title><source>J. Infect. Dis.</source><year>2020</year><volume>221</volume><fpage>S94</fpage><lpage>S102</lpage><pub-id pub-id-type="doi">10.1093/infdis/jiz638</pub-id><pub-id pub-id-type="pmid">32134490</pub-id>
</element-citation></ref><ref id="B64-viruses-16-01809"><label>64.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Gafa</surname><given-names>V.</given-names></name>
<name><surname>Manches</surname><given-names>O.</given-names></name>
<name><surname>Pastor</surname><given-names>A.</given-names></name>
<name><surname>Drouet</surname><given-names>E.</given-names></name>
<name><surname>Ambroise-Thomas</surname><given-names>P.</given-names></name>
<name><surname>Grillot</surname><given-names>R.</given-names></name>
<name><surname>Aldebert</surname><given-names>D.</given-names></name>
</person-group><article-title>Human cytomegalovirus downregulates complement receptors (CR3, CR4) and decreases phagocytosis by macrophages</article-title><source>J. Med Virol.</source><year>2005</year><volume>76</volume><fpage>361</fpage><lpage>366</lpage><pub-id pub-id-type="doi">10.1002/jmv.20358</pub-id><pub-id pub-id-type="pmid">15902695</pub-id>
</element-citation></ref><ref id="B65-viruses-16-01809"><label>65.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Jaworowski</surname><given-names>A.</given-names></name>
<name><surname>Cheng</surname><given-names>W.-J.</given-names></name>
<name><surname>Westhorpe</surname><given-names>C.L.</given-names></name>
<name><surname>Abendroth</surname><given-names>A.</given-names></name>
<name><surname>Crowe</surname><given-names>S.M.</given-names></name>
<name><surname>Slobedman</surname><given-names>B.</given-names></name>
</person-group><article-title>Enhanced monocyte Fc phagocytosis by a homologue of interleukin-10 encoded by human cytomegalovirus</article-title><source>Virology</source><year>2009</year><volume>391</volume><fpage>20</fpage><lpage>24</lpage><pub-id pub-id-type="doi">10.1016/j.virol.2009.06.003</pub-id><pub-id pub-id-type="pmid">19564031</pub-id>
</element-citation></ref><ref id="B66-viruses-16-01809"><label>66.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Kotenko</surname><given-names>S.V.</given-names></name>
<name><surname>Saccani</surname><given-names>S.</given-names></name>
<name><surname>Izotova</surname><given-names>L.S.</given-names></name>
<name><surname>Mirochnitchenko</surname><given-names>O.V.</given-names></name>
<name><surname>Pestka</surname><given-names>S.</given-names></name>
</person-group><article-title>Human cytomegalovirus harbors its own unique IL-10 homolog (cmvIL-10)</article-title><source>Proc. Natl. Acad. Sci. USA</source><year>2000</year><volume>97</volume><fpage>1695</fpage><lpage>1700</lpage><pub-id pub-id-type="doi">10.1073/pnas.97.4.1695</pub-id><pub-id pub-id-type="pmid">10677520</pub-id>
</element-citation></ref><ref id="B67-viruses-16-01809"><label>67.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Poole</surname><given-names>E.</given-names></name>
<name><surname>Neves</surname><given-names>T.C.</given-names></name>
<name><surname>Oliveira</surname><given-names>M.T.</given-names></name>
<name><surname>Sinclair</surname><given-names>J.</given-names></name>
<name><surname>da Silva</surname><given-names>M.C.C.</given-names></name>
</person-group><article-title>Human Cytomegalovirus Interleukin 10 Homologs: Facing the Immune System</article-title><source>Front. Cell. Infect. Microbiol.</source><year>2020</year><volume>10</volume><elocation-id>245</elocation-id><pub-id pub-id-type="doi">10.3389/fcimb.2020.00245</pub-id><pub-id pub-id-type="pmid">32582563</pub-id>
</element-citation></ref><ref id="B68-viruses-16-01809"><label>68.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Corrales-Aguilar</surname><given-names>E.</given-names></name>
<name><surname>Trilling</surname><given-names>M.</given-names></name>
<name><surname>Hunold</surname><given-names>K.</given-names></name>
<name><surname>Fiedler</surname><given-names>M.</given-names></name>
<name><surname>Le</surname><given-names>V.T.K.</given-names></name>
<name><surname>Reinhard</surname><given-names>H.</given-names></name>
<name><surname>Ehrhardt</surname><given-names>K.</given-names></name>
<name><surname>Merc&#x000e9;-Maldonado</surname><given-names>E.</given-names></name>
<name><surname>Aliyev</surname><given-names>E.</given-names></name>
<name><surname>Zimmermann</surname><given-names>A.</given-names></name>
<etal/>
</person-group><article-title>Human cytomegalovirus Fcgamma binding proteins gp34 and gp68 antagonize Fcgamma receptors I, II and III</article-title><source>PLoS Pathog.</source><year>2014</year><volume>10</volume><elocation-id>e1004131</elocation-id><pub-id pub-id-type="doi">10.1371/journal.ppat.1004131</pub-id><pub-id pub-id-type="pmid">24830376</pub-id>
</element-citation></ref><ref id="B69-viruses-16-01809"><label>69.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Gredmark</surname><given-names>S.</given-names></name>
<name><surname>S&#x000f6;derberg-Naucl&#x000e9;r</surname><given-names>C.</given-names></name>
</person-group><article-title>Human Cytomegalovirus Inhibits Differentiation of Monocytes into Dendritic Cells with the Consequence of Depressed Immunological Functions</article-title><source>J. Virol.</source><year>2003</year><volume>77</volume><fpage>10943</fpage><lpage>10956</lpage><pub-id pub-id-type="doi">10.1128/JVI.77.20.10943-10956.2003</pub-id><pub-id pub-id-type="pmid">14512544</pub-id>
</element-citation></ref><ref id="B70-viruses-16-01809"><label>70.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Grigoleit</surname><given-names>U.</given-names></name>
<name><surname>Riegler</surname><given-names>S.</given-names></name>
<name><surname>Einsele</surname><given-names>H.</given-names></name>
<name><surname>Sampaio</surname><given-names>K.L.</given-names></name>
<name><surname>Jahn</surname><given-names>G.</given-names></name>
<name><surname>Hebart</surname><given-names>H.</given-names></name>
<name><surname>Brossart</surname><given-names>P.</given-names></name>
<name><surname>Frank</surname><given-names>F.</given-names></name>
<name><surname>Sinzger</surname><given-names>C.</given-names></name>
</person-group><article-title>Human cytomegalovirus induces a direct inhibitory effect on antigen presentation by monocyte-derived immature dendritic cells</article-title><source>Br. J. Haematol.</source><year>2002</year><volume>119</volume><fpage>189</fpage><lpage>198</lpage><pub-id pub-id-type="doi">10.1046/j.1365-2141.2002.03798.x</pub-id><pub-id pub-id-type="pmid">12358925</pub-id>
</element-citation></ref><ref id="B71-viruses-16-01809"><label>71.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Moutaftsi</surname><given-names>M.</given-names></name>
<name><surname>Mehl</surname><given-names>A.M.</given-names></name>
<name><surname>Borysiewicz</surname><given-names>L.K.</given-names></name>
<name><surname>Tabi</surname><given-names>Z.</given-names></name>
</person-group><article-title>Human cytomegalovirus inhibits maturation and impairs function of monocyte-derived dendritic cells</article-title><source>Blood</source><year>2002</year><volume>99</volume><fpage>2913</fpage><lpage>2921</lpage><pub-id pub-id-type="doi">10.1182/blood.V99.8.2913</pub-id><pub-id pub-id-type="pmid">11929782</pub-id>
</element-citation></ref><ref id="B72-viruses-16-01809"><label>72.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Banchereau</surname><given-names>J.</given-names></name>
<name><surname>Steinman</surname><given-names>R.M.</given-names></name>
</person-group><article-title>Dendritic cells and the control of immunity</article-title><source>Nature</source><year>1998</year><volume>392</volume><fpage>245</fpage><lpage>252</lpage><pub-id pub-id-type="doi">10.1038/32588</pub-id><pub-id pub-id-type="pmid">9521319</pub-id>
</element-citation></ref><ref id="B73-viruses-16-01809"><label>73.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Reddehase</surname><given-names>M.J.</given-names></name>
</person-group><article-title>Antigens and immunoevasins: Opponents in cytomegalovirus immune surveillance</article-title><source>Nat. Rev. Immunol.</source><year>2002</year><volume>2</volume><fpage>831</fpage><lpage>844</lpage><pub-id pub-id-type="doi">10.1038/nri932</pub-id><pub-id pub-id-type="pmid">12415307</pub-id>
</element-citation></ref><ref id="B74-viruses-16-01809"><label>74.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Ahn</surname><given-names>K.</given-names></name>
<name><surname>Angulo</surname><given-names>A.</given-names></name>
<name><surname>Ghazal</surname><given-names>P.</given-names></name>
<name><surname>Peterson</surname><given-names>P.A.</given-names></name>
<name><surname>Yang</surname><given-names>Y.</given-names></name>
<name><surname>Fr&#x000fc;h</surname><given-names>K.</given-names></name>
</person-group><article-title>Human cytomegalovirus inhibits antigen presentation by a sequential multistep process</article-title><source>Proc. Natl. Acad. Sci. USA</source><year>1996</year><volume>93</volume><fpage>10990</fpage><lpage>10995</lpage><pub-id pub-id-type="doi">10.1073/pnas.93.20.10990</pub-id><pub-id pub-id-type="pmid">8855296</pub-id>
</element-citation></ref><ref id="B75-viruses-16-01809"><label>75.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Jones</surname><given-names>T.R.</given-names></name>
<name><surname>Wiertz</surname><given-names>E.J.</given-names></name>
<name><surname>Sun</surname><given-names>L.</given-names></name>
<name><surname>Fish</surname><given-names>K.N.</given-names></name>
<name><surname>Nelson</surname><given-names>J.A.</given-names></name>
<name><surname>Ploegh</surname><given-names>H.L.</given-names></name>
</person-group><article-title>Human cytomegalovirus US3 impairs transport and maturation of major histocompatibility complex class I heavy chains</article-title><source>Proc. Natl. Acad. Sci. USA</source><year>1996</year><volume>93</volume><fpage>11327</fpage><lpage>11333</lpage><pub-id pub-id-type="doi">10.1073/pnas.93.21.11327</pub-id><pub-id pub-id-type="pmid">8876135</pub-id>
</element-citation></ref><ref id="B76-viruses-16-01809"><label>76.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Furman</surname><given-names>M.H.</given-names></name>
<name><surname>Dey</surname><given-names>N.</given-names></name>
<name><surname>Tortorella</surname><given-names>D.</given-names></name>
<name><surname>Ploegh</surname><given-names>H.L.</given-names></name>
</person-group><article-title>The Human Cytomegalovirus US10 Gene Product Delays Trafficking of Major Histocompatibility Complex Class I Molecules</article-title><source>J. Virol.</source><year>2002</year><volume>76</volume><fpage>11753</fpage><lpage>11756</lpage><pub-id pub-id-type="doi">10.1128/JVI.76.22.11753-11756.2002</pub-id><pub-id pub-id-type="pmid">12388737</pub-id>
</element-citation></ref><ref id="B77-viruses-16-01809"><label>77.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Lehner</surname><given-names>P.J.</given-names></name>
<name><surname>Karttunen</surname><given-names>J.T.</given-names></name>
<name><surname>Wilkinson</surname><given-names>G.W.G.</given-names></name>
<name><surname>Cresswell</surname><given-names>P.</given-names></name>
</person-group><article-title>The human cytomegalovirus US6 glycoprotein inhibits transporter associated with antigen processing-dependent peptide translocation</article-title><source>Proc. Natl. Acad. Sci. USA</source><year>1997</year><volume>94</volume><fpage>6904</fpage><lpage>6909</lpage><pub-id pub-id-type="doi">10.1073/pnas.94.13.6904</pub-id><pub-id pub-id-type="pmid">9192664</pub-id>
</element-citation></ref><ref id="B78-viruses-16-01809"><label>78.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Gewurz</surname><given-names>B.E.</given-names></name>
<name><surname>Gaudet</surname><given-names>R.</given-names></name>
<name><surname>Tortorella</surname><given-names>D.</given-names></name>
<name><surname>Wang</surname><given-names>E.W.</given-names></name>
<name><surname>Ploegh</surname><given-names>H.L.</given-names></name>
<name><surname>Wiley</surname><given-names>D.C.</given-names></name>
</person-group><article-title>Antigen presentation subverted: Structure of the human cytomegalovirus protein US2 bound to the class I molecule HLA-A2</article-title><source>Proc. Natl. Acad. Sci. USA</source><year>2001</year><volume>98</volume><fpage>6794</fpage><lpage>6799</lpage><pub-id pub-id-type="doi">10.1073/pnas.121172898</pub-id><pub-id pub-id-type="pmid">11391001</pub-id>
</element-citation></ref><ref id="B79-viruses-16-01809"><label>79.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Compton</surname><given-names>T.</given-names></name>
<name><surname>Kurt-Jones</surname><given-names>E.A.</given-names></name>
<name><surname>Boehme</surname><given-names>K.W.</given-names></name>
<name><surname>Belko</surname><given-names>J.</given-names></name>
<name><surname>Latz</surname><given-names>E.</given-names></name>
<name><surname>Golenbock</surname><given-names>D.T.</given-names></name>
<name><surname>Finberg</surname><given-names>R.W.</given-names></name>
</person-group><article-title>Human cytomegalovirus activates inflammatory cytokine responses via CD14 and Toll-like receptor 2</article-title><source>J. Virol.</source><year>2003</year><volume>77</volume><fpage>4588</fpage><lpage>4596</lpage><pub-id pub-id-type="doi">10.1128/JVI.77.8.4588-4596.2003</pub-id><pub-id pub-id-type="pmid">12663765</pub-id>
</element-citation></ref><ref id="B80-viruses-16-01809"><label>80.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Smith</surname><given-names>P.D.</given-names></name>
<name><surname>Saini</surname><given-names>S.S.</given-names></name>
<name><surname>Raffeld</surname><given-names>M.</given-names></name>
<name><surname>Manischewitz</surname><given-names>J.F.</given-names></name>
<name><surname>Wahl</surname><given-names>S.M.</given-names></name>
</person-group><article-title>Cytomegalovirus induction of tumor necrosis factor-alpha by human monocytes and mucosal macrophages</article-title><source>J. Clin. Investig.</source><year>1992</year><volume>90</volume><fpage>1642</fpage><lpage>1648</lpage><pub-id pub-id-type="doi">10.1172/JCI116035</pub-id><pub-id pub-id-type="pmid">1331170</pub-id>
</element-citation></ref><ref id="B81-viruses-16-01809"><label>81.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Yurochko</surname><given-names>A.D.</given-names></name>
<name><surname>Huang</surname><given-names>E.-S.</given-names></name>
</person-group><article-title>Human Cytomegalovirus Binding to Human Monocytes Induces Immunoregulatory Gene Expression</article-title><source>J. Immunol.</source><year>1999</year><volume>162</volume><fpage>4806</fpage><lpage>4816</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.162.8.4806</pub-id><pub-id pub-id-type="pmid">10202024</pub-id>
</element-citation></ref><ref id="B82-viruses-16-01809"><label>82.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Allavena</surname><given-names>P.</given-names></name>
<name><surname>Piemonti</surname><given-names>L.</given-names></name>
<name><surname>Longoni</surname><given-names>D.</given-names></name>
<name><surname>Bernasconi</surname><given-names>S.</given-names></name>
<name><surname>Stoppacciaro</surname><given-names>A.</given-names></name>
<name><surname>Ruco</surname><given-names>L.</given-names></name>
<name><surname>Mantovani</surname><given-names>A.</given-names></name>
</person-group><article-title>IL-10 prevents the differentiation of monocytes to dendritic cells but promotes their maturation to macrophages</article-title><source>Eur. J. Immunol.</source><year>1998</year><volume>28</volume><fpage>359</fpage><lpage>369</lpage><pub-id pub-id-type="doi">10.1002/(SICI)1521-4141(199801)28:01&#x0003c;359::AID-IMMU359&#x0003e;3.0.CO;2-4</pub-id><pub-id pub-id-type="pmid">9485215</pub-id>
</element-citation></ref><ref id="B83-viruses-16-01809"><label>83.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Hancock</surname><given-names>M.H.</given-names></name>
<name><surname>Hook</surname><given-names>L.M.</given-names></name>
<name><surname>Mitchell</surname><given-names>J.</given-names></name>
<name><surname>Nelson</surname><given-names>J.A.</given-names></name>
</person-group><article-title>Human Cytomegalovirus MicroRNAs miR-US5-1 and miR-UL112-3p Block Proinflammatory Cytokine Production in Response to NF-&#x003ba;B-Activating Factors through Direct Downregulation of IKK&#x003b1; and IKK&#x003b2;</article-title><source>mBio</source><year>2017</year><volume>8</volume><fpage>e00109-17</fpage><pub-id pub-id-type="doi">10.1128/mBio.00109-17</pub-id><pub-id pub-id-type="pmid">28270578</pub-id>
</element-citation></ref><ref id="B84-viruses-16-01809"><label>84.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Frascaroli</surname><given-names>G.</given-names></name>
<name><surname>Varani</surname><given-names>S.</given-names></name>
<name><surname>Moepps</surname><given-names>B.</given-names></name>
<name><surname>Sinzger</surname><given-names>C.</given-names></name>
<name><surname>Landini</surname><given-names>M.P.</given-names></name>
<name><surname>Mertens</surname><given-names>T.</given-names></name>
</person-group><article-title>Human Cytomegalovirus Subverts the Functions of Monocytes, Impairing Chemokine-Mediated Migration and Leukocyte Recruitment</article-title><source>J. Virol.</source><year>2006</year><volume>80</volume><fpage>7578</fpage><lpage>7589</lpage><pub-id pub-id-type="doi">10.1128/JVI.02421-05</pub-id><pub-id pub-id-type="pmid">16840337</pub-id>
</element-citation></ref><ref id="B85-viruses-16-01809"><label>85.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Smith</surname><given-names>M.S.</given-names></name>
<name><surname>Bentz</surname><given-names>G.L.</given-names></name>
<name><surname>Alexander</surname><given-names>J.S.</given-names></name>
<name><surname>Yurochko</surname><given-names>A.D.</given-names></name>
</person-group><article-title>Human Cytomegalovirus Induces Monocyte Differentiation and Migration as a Strategy for Dissemination and Persistence</article-title><source>J. Virol.</source><year>2004</year><volume>78</volume><fpage>4444</fpage><lpage>4453</lpage><pub-id pub-id-type="doi">10.1128/JVI.78.9.4444-4453.2004</pub-id><pub-id pub-id-type="pmid">15078925</pub-id>
</element-citation></ref><ref id="B86-viruses-16-01809"><label>86.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Bentz</surname><given-names>G.L.</given-names></name>
<name><surname>Jarquin-Pardo</surname><given-names>M.</given-names></name>
<name><surname>Chan</surname><given-names>G.</given-names></name>
<name><surname>Smith</surname><given-names>M.S.</given-names></name>
<name><surname>Sinzger</surname><given-names>C.</given-names></name>
<name><surname>Yurochko</surname><given-names>A.D.</given-names></name>
</person-group><article-title>Human Cytomegalovirus (HCMV) Infection of Endothelial Cells Promotes Na&#x000ef;ve Monocyte Extravasation and Transfer of Productive Virus To Enhance Hematogenous Dissemination of HCMV</article-title><source>J. Virol.</source><year>2006</year><volume>80</volume><fpage>11539</fpage><lpage>11555</lpage><pub-id pub-id-type="doi">10.1128/JVI.01016-06</pub-id><pub-id pub-id-type="pmid">16987970</pub-id>
</element-citation></ref><ref id="B87-viruses-16-01809"><label>87.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Sedgwick</surname><given-names>A.D.</given-names></name>
<name><surname>Edwards</surname><given-names>J.C.W.</given-names></name>
<name><surname>Willoughby</surname><given-names>D.A.</given-names></name>
</person-group><article-title>Studies on the ability of inflammatory exudate obtained from acute and chronic phases of the inflammatory process to promote leukocyte locomotion in vitro</article-title><source>Inflammation</source><year>1982</year><volume>6</volume><fpage>13</fpage><lpage>20</lpage><pub-id pub-id-type="doi">10.1007/BF00910715</pub-id><pub-id pub-id-type="pmid">7085042</pub-id>
</element-citation></ref><ref id="B88-viruses-16-01809"><label>88.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Saederup</surname><given-names>N.</given-names></name>
<name><surname>Lin</surname><given-names>Y.C.</given-names></name>
<name><surname>Dairaghi</surname><given-names>D.J.</given-names></name>
<name><surname>Schall</surname><given-names>T.J.</given-names></name>
<name><surname>Mocarski</surname><given-names>E.S.</given-names></name>
</person-group><article-title>Cytomegalovirus-encoded &#x003b2; chemokine promotes monocyte-associated viremia in the host</article-title><source>Proc. Natl. Acad. Sci. USA</source><year>1999</year><volume>96</volume><fpage>10881</fpage><lpage>10886</lpage><pub-id pub-id-type="doi">10.1073/pnas.96.19.10881</pub-id><pub-id pub-id-type="pmid">10485920</pub-id>
</element-citation></ref><ref id="B89-viruses-16-01809"><label>89.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Zheng</surname><given-names>Q.</given-names></name>
<name><surname>Tao</surname><given-names>R.</given-names></name>
<name><surname>Gao</surname><given-names>H.</given-names></name>
<name><surname>Xu</surname><given-names>J.</given-names></name>
<name><surname>Shang</surname><given-names>S.</given-names></name>
<name><surname>Zhao</surname><given-names>N.</given-names></name>
</person-group><article-title>HCMV-encoded UL128 enhances TNF-alpha and IL-6 expression and promotes PBMC proliferation through the MAPK/ERK pathway in vitro</article-title><source>Viral Immunol.</source><year>2012</year><volume>25</volume><fpage>98</fpage><lpage>105</lpage><pub-id pub-id-type="doi">10.1089/vim.2011.0064</pub-id><pub-id pub-id-type="pmid">22486303</pub-id>
</element-citation></ref><ref id="B90-viruses-16-01809"><label>90.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>McSharry</surname><given-names>B.P.</given-names></name>
<name><surname>Avdic</surname><given-names>S.</given-names></name>
<name><surname>Slobedman</surname><given-names>B.</given-names></name>
</person-group><article-title>Human Cytomegalovirus Encoded Homologs of Cytokines, Chemokines and their Receptors: Roles in Immunomodulation</article-title><source>Viruses</source><year>2012</year><volume>4</volume><fpage>2448</fpage><lpage>2470</lpage><pub-id pub-id-type="doi">10.3390/v4112448</pub-id><pub-id pub-id-type="pmid">23202490</pub-id>
</element-citation></ref><ref id="B91-viruses-16-01809"><label>91.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Billstrom</surname><given-names>M.A.</given-names></name>
<name><surname>Johnson</surname><given-names>G.L.</given-names></name>
<name><surname>Avdi</surname><given-names>N.J.</given-names></name>
<name><surname>Worthen</surname><given-names>G.S.</given-names></name>
</person-group><article-title>Intracellular Signaling by the Chemokine Receptor US28 during Human Cytomegalovirus Infection</article-title><source>J. Virol.</source><year>1998</year><volume>72</volume><fpage>5535</fpage><lpage>5544</lpage><pub-id pub-id-type="doi">10.1128/JVI.72.7.5535-5544.1998</pub-id><pub-id pub-id-type="pmid">9621010</pub-id>
</element-citation></ref><ref id="B92-viruses-16-01809"><label>92.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Gredmark</surname><given-names>S.</given-names></name>
<name><surname>Tilburgs</surname><given-names>T.</given-names></name>
<name><surname>S&#x000f6;derberg-Naucl&#x000e9;r</surname><given-names>C.</given-names></name>
</person-group><article-title>Human cytomegalovirus inhibits cytokine-induced macrophage differentiation</article-title><source>J. Virol.</source><year>2004</year><volume>78</volume><fpage>10378</fpage><lpage>10389</lpage><pub-id pub-id-type="doi">10.1128/JVI.78.19.10378-10389.2004</pub-id><pub-id pub-id-type="pmid">15367604</pub-id>
</element-citation></ref><ref id="B93-viruses-16-01809"><label>93.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Guetta</surname><given-names>E.</given-names></name>
<name><surname>Guetta</surname><given-names>V.</given-names></name>
<name><surname>Shibutani</surname><given-names>T.</given-names></name>
<name><surname>Epstein</surname><given-names>S.E.</given-names></name>
<name><surname>Speir</surname><given-names>E.</given-names></name>
<name><surname>Yu</surname><given-names>Z.-X.</given-names></name>
<name><surname>Ferrans</surname><given-names>V.J.</given-names></name>
<name><surname>Huang</surname><given-names>E.-S.</given-names></name>
<name><surname>Froberg</surname><given-names>M.K.</given-names></name>
<name><surname>Adams</surname><given-names>A.</given-names></name>
<etal/>
</person-group><article-title>Monocytes harboring cytomegalovirus: Interactions with endothelial cells, smooth muscle cells, and oxidized low-density lipoprotein. Possible mechanisms for activating virus delivered by monocytes to sites of vascular injury</article-title><source>Circ. Res.</source><year>1997</year><volume>81</volume><fpage>8</fpage><lpage>16</lpage><pub-id pub-id-type="doi">10.1161/01.RES.81.1.8</pub-id><pub-id pub-id-type="pmid">9201022</pub-id>
</element-citation></ref><ref id="B94-viruses-16-01809"><label>94.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Carlier</surname><given-names>J.</given-names></name>
<name><surname>Martin</surname><given-names>H.</given-names></name>
<name><surname>Mariam&#x000e9;</surname><given-names>B.</given-names></name>
<name><surname>Rauwel</surname><given-names>B.</given-names></name>
<name><surname>Mengelle</surname><given-names>C.</given-names></name>
<name><surname>Weclawiak</surname><given-names>H.</given-names></name>
<name><surname>Coaquette</surname><given-names>A.</given-names></name>
<name><surname>Vauchy</surname><given-names>C.</given-names></name>
<name><surname>Rohrlich</surname><given-names>P.</given-names></name>
<name><surname>Kamar</surname><given-names>N.</given-names></name>
<etal/>
</person-group><article-title>Paracrine inhibition of GM-CSF signaling by human cytomegalovirus in monocytes differentiating to dendritic cells</article-title><source>Blood</source><year>2011</year><volume>118</volume><fpage>6783</fpage><lpage>6792</lpage><pub-id pub-id-type="doi">10.1182/blood-2011-02-337956</pub-id><pub-id pub-id-type="pmid">22031867</pub-id>
</element-citation></ref><ref id="B95-viruses-16-01809"><label>95.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Schieber</surname><given-names>M.</given-names></name>
<name><surname>Chandel</surname><given-names>N.S.</given-names></name>
</person-group><article-title>ROS Function in Redox Signaling and Oxidative Stress</article-title><source>Curr. Biol.</source><year>2014</year><volume>24</volume><fpage>R453</fpage><lpage>R462</lpage><pub-id pub-id-type="doi">10.1016/j.cub.2014.03.034</pub-id><pub-id pub-id-type="pmid">24845678</pub-id>
</element-citation></ref><ref id="B96-viruses-16-01809"><label>96.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Ch&#x000e2;teau</surname><given-names>M.-T.</given-names></name>
<name><surname>Rabesandratana</surname><given-names>H.</given-names></name>
<name><surname>Caravano</surname><given-names>R.</given-names></name>
</person-group><article-title>Differentiated U937 cells and human monocytes exhibit a differential production of extracellular oxygen species: O2.- excretion versus H2O2 diffusion</article-title><source>FEMS Immunol. Med Microbiol.</source><year>1996</year><volume>13</volume><fpage>19</fpage><lpage>28</lpage><pub-id pub-id-type="doi">10.1016/0928-8244(95)00076-3</pub-id><pub-id pub-id-type="pmid">8821394</pub-id>
</element-citation></ref><ref id="B97-viruses-16-01809"><label>97.</label><element-citation publication-type="book"><person-group person-group-type="author">
<name><surname>Nathan</surname><given-names>C.F.</given-names></name>
<name><surname>Gabay</surname><given-names>J.</given-names></name>
</person-group><article-title>Antimicrobial mechanisms of macrophages</article-title><source>Mononuclear Phagocytes</source><person-group person-group-type="editor">
<name><surname>Furth</surname><given-names>R.V.</given-names></name>
</person-group><publisher-name>Kluwer Academic Publishers</publisher-name><publisher-loc>Dordrecht, The Netherlands</publisher-loc><year>1992</year><comment>Chapter 34</comment><fpage>259</fpage><lpage>267</lpage></element-citation></ref><ref id="B98-viruses-16-01809"><label>98.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Thannickal</surname><given-names>V.J.</given-names></name>
<name><surname>Fanburg</surname><given-names>B.L.</given-names></name>
</person-group><article-title>Reactive oxygen species in cell signaling</article-title><source>Am. J. Physiol. Cell. Mol. Physiol.</source><year>2000</year><volume>279</volume><fpage>L1005</fpage><lpage>L1028</lpage><pub-id pub-id-type="doi">10.1152/ajplung.2000.279.6.L1005</pub-id></element-citation></ref><ref id="B99-viruses-16-01809"><label>99.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Suzuki</surname><given-names>S.</given-names></name>
<name><surname>Kameoka</surname><given-names>M.</given-names></name>
<name><surname>Nakaya</surname><given-names>T.</given-names></name>
<name><surname>Kimura</surname><given-names>T.</given-names></name>
<name><surname>Nishi</surname><given-names>N.</given-names></name>
<name><surname>Hirai</surname><given-names>K.</given-names></name>
<name><surname>Ikuta</surname><given-names>K.</given-names></name>
</person-group><article-title>Superoxide generation by monocytes following infection with human cytomegalovirus</article-title><source>Immunopharmacology</source><year>1997</year><volume>37</volume><fpage>185</fpage><lpage>190</lpage><pub-id pub-id-type="doi">10.1016/S0162-3109(97)00047-7</pub-id><pub-id pub-id-type="pmid">9403337</pub-id>
</element-citation></ref><ref id="B100-viruses-16-01809"><label>100.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Xu</surname><given-names>X.</given-names></name>
<name><surname>Cai</surname><given-names>J.</given-names></name>
<name><surname>Wang</surname><given-names>X.</given-names></name>
<name><surname>Lu</surname><given-names>Y.</given-names></name>
<name><surname>Guo</surname><given-names>B.</given-names></name>
<name><surname>Lai</surname><given-names>M.</given-names></name>
<name><surname>Lan</surname><given-names>L.</given-names></name>
<name><surname>Peng</surname><given-names>Y.</given-names></name>
<name><surname>Zheng</surname><given-names>X.</given-names></name>
</person-group><article-title>Human cytomegalovirus infection activates NLRP3 inflammasome by releasing mtDNA into the cytosol in human THP-1 cells</article-title><source>Microbiol. Immunol.</source><year>2023</year><volume>67</volume><fpage>303</fpage><lpage>313</lpage><pub-id pub-id-type="doi">10.1111/1348-0421.13063</pub-id><pub-id pub-id-type="pmid">36932814</pub-id>
</element-citation></ref><ref id="B101-viruses-16-01809"><label>101.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Speir</surname><given-names>E.</given-names></name>
<name><surname>Shibutani</surname><given-names>T.</given-names></name>
<name><surname>Yu</surname><given-names>Z.-X.</given-names></name>
<name><surname>Ferrans</surname><given-names>V.</given-names></name>
<name><surname>Epstein</surname><given-names>S.E.</given-names></name>
</person-group><article-title>Role of reactive oxygen intermediates in cytomegalovirus gene expression and in the response of human smooth muscle cells to viral infection</article-title><source>Circ. Res.</source><year>1996</year><volume>79</volume><fpage>1143</fpage><lpage>1152</lpage><pub-id pub-id-type="doi">10.1161/01.RES.79.6.1143</pub-id><pub-id pub-id-type="pmid">8943952</pub-id>
</element-citation></ref><ref id="B102-viruses-16-01809"><label>102.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Monk</surname><given-names>C.H.</given-names></name>
<name><surname>Zwezdaryk</surname><given-names>K.J.</given-names></name>
</person-group><article-title>Host Mitochondrial Requirements of Cytomegalovirus Replication</article-title><source>Curr. Clin. Microbiol. Rep.</source><year>2020</year><volume>7</volume><fpage>115</fpage><lpage>123</lpage><pub-id pub-id-type="doi">10.1007/s40588-020-00153-5</pub-id><pub-id pub-id-type="pmid">33816061</pub-id>
</element-citation></ref><ref id="B103-viruses-16-01809"><label>103.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Perera</surname><given-names>M.R.</given-names></name>
<name><surname>Sinclair</surname><given-names>J.H.</given-names></name>
</person-group><article-title>The Human Cytomegalovirus beta2.7 Long Non-Coding RNA Prevents Induction of Reactive Oxygen Species to Maintain Viral Gene Silencing during Latency</article-title><source>Int. J. Mol. Sci.</source><year>2022</year><volume>23</volume><elocation-id>11017</elocation-id><pub-id pub-id-type="doi">10.3390/ijms231911017</pub-id><pub-id pub-id-type="pmid">36232315</pub-id>
</element-citation></ref><ref id="B104-viruses-16-01809"><label>104.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Papon</surname><given-names>N.</given-names></name>
<name><surname>Nevez</surname><given-names>G.</given-names></name>
<name><surname>Le Gal</surname><given-names>S.</given-names></name>
<name><surname>Vigneau</surname><given-names>C.</given-names></name>
<name><surname>Robert-Gangneux</surname><given-names>F.</given-names></name>
<name><surname>Bouchara</surname><given-names>J.-P.</given-names></name>
<name><surname>Cornely</surname><given-names>O.A.</given-names></name>
<name><surname>Denning</surname><given-names>D.W.</given-names></name>
<name><surname>Gangneux</surname><given-names>J.-P.</given-names></name>
</person-group><article-title>Fungal infections in transplant recipients: Pros and cons of immunosuppressive and antimicrobial treatment</article-title><source>Lancet Microbe</source><year>2021</year><volume>2</volume><fpage>e6</fpage><lpage>e8</lpage><pub-id pub-id-type="doi">10.1016/S2666-5247(20)30199-3</pub-id><pub-id pub-id-type="pmid">35544229</pub-id>
</element-citation></ref><ref id="B105-viruses-16-01809"><label>105.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Pappas</surname><given-names>P.G.</given-names></name>
<name><surname>Alexander</surname><given-names>B.D.</given-names></name>
<name><surname>Andes</surname><given-names>D.R.</given-names></name>
<name><surname>Hadley</surname><given-names>S.</given-names></name>
<name><surname>Kauffman</surname><given-names>C.A.</given-names></name>
<name><surname>Freifeld</surname><given-names>A.</given-names></name>
<name><surname>Anaissie</surname><given-names>E.J.</given-names></name>
<name><surname>Brumble</surname><given-names>L.M.</given-names></name>
<name><surname>Herwaldt</surname><given-names>L.</given-names></name>
<name><surname>Ito</surname><given-names>J.</given-names></name>
<etal/>
</person-group><article-title>Invasive Fungal Infections among Organ Transplant Recipients: Results of the Transplant-Associated Infection Surveillance Network (TRANSNET)</article-title><source>Clin. Infect. Dis.</source><year>2010</year><volume>50</volume><fpage>1101</fpage><lpage>1111</lpage><pub-id pub-id-type="doi">10.1086/651262</pub-id><pub-id pub-id-type="pmid">20218876</pub-id>
</element-citation></ref><ref id="B106-viruses-16-01809"><label>106.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Wang</surname><given-names>H.</given-names></name>
<name><surname>Peng</surname><given-names>G.</given-names></name>
<name><surname>Bai</surname><given-names>J.</given-names></name>
<name><surname>He</surname><given-names>B.</given-names></name>
<name><surname>Huang</surname><given-names>K.</given-names></name>
<name><surname>Hu</surname><given-names>X.</given-names></name>
<name><surname>Liu</surname><given-names>D.</given-names></name>
</person-group><article-title>Cytomegalovirus Infection and Relative Risk of Cardiovascular Disease (Ischemic Heart Disease, Stroke, and Cardiovascular Death): A Meta-Analysis of Prospective Studies Up to 2016</article-title><source>J. Am. Hear. Assoc.</source><year>2017</year><volume>6</volume><fpage>e005025</fpage><pub-id pub-id-type="doi">10.1161/JAHA.116.005025</pub-id><pub-id pub-id-type="pmid">28684641</pub-id>
</element-citation></ref><ref id="B107-viruses-16-01809"><label>107.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Baasch</surname><given-names>S.</given-names></name>
<name><surname>Ruzsics</surname><given-names>Z.</given-names></name>
<name><surname>Henneke</surname><given-names>P.</given-names></name>
</person-group><article-title>Cytomegaloviruses and Macrophages&#x02014;Friends and Foes From Early on?</article-title><source>Front. Immunol.</source><year>2020</year><volume>11</volume><elocation-id>793</elocation-id><pub-id pub-id-type="doi">10.3389/fimmu.2020.00793</pub-id><pub-id pub-id-type="pmid">32477336</pub-id>
</element-citation></ref><ref id="B108-viruses-16-01809"><label>108.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Weigt</surname><given-names>S.S.</given-names></name>
<name><surname>Palchevskiy</surname><given-names>V.</given-names></name>
<name><surname>Belperio</surname><given-names>J.A.</given-names></name>
</person-group><article-title>Inflammasomes and IL-1 biology in the pathogenesis of allograft dysfunction</article-title><source>J. Clin. Investig.</source><year>2017</year><volume>127</volume><fpage>2022</fpage><lpage>2029</lpage><pub-id pub-id-type="doi">10.1172/JCI93537</pub-id><pub-id pub-id-type="pmid">28569730</pub-id>
</element-citation></ref><ref id="B109-viruses-16-01809"><label>109.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Deml</surname><given-names>L.</given-names></name>
<name><surname>H&#x000fc;ber</surname><given-names>C.M.</given-names></name>
<name><surname>Barabas</surname><given-names>S.</given-names></name>
<name><surname>Spindler</surname><given-names>T.B.</given-names></name>
<name><surname>Cozzi</surname><given-names>E.</given-names></name>
<name><surname>Grossi</surname><given-names>P.</given-names></name>
</person-group><article-title>Stimulatory Effect of CMV Immunoglobulin on Innate Immunity and on the Immunogenicity of CMV Antigens</article-title><source>Transplant. Direct</source><year>2021</year><volume>7</volume><fpage>e781</fpage><pub-id pub-id-type="doi">10.1097/TXD.0000000000001236</pub-id><pub-id pub-id-type="pmid">34712781</pub-id>
</element-citation></ref></ref-list></back><floats-group><fig position="float" id="viruses-16-01809-f001"><label>Figure 1</label><caption><p>Monocyte effector functions.</p></caption><graphic xlink:href="viruses-16-01809-g001" position="float"/></fig><fig position="float" id="viruses-16-01809-f002"><label>Figure 2</label><caption><p>CMV interacts with monocytes via &#x003b2;1 and &#x003b2;3 integrins and EGFR.</p></caption><graphic xlink:href="viruses-16-01809-g002" position="float"/></fig><fig position="float" id="viruses-16-01809-f003"><label>Figure 3</label><caption><p>CMV infection modulates monocyte phagocytic function.</p></caption><graphic xlink:href="viruses-16-01809-g003" position="float"/></fig><fig position="float" id="viruses-16-01809-f004"><label>Figure 4</label><caption><p>CMV modulates antigen presentation by monocytes.</p></caption><graphic xlink:href="viruses-16-01809-g004" position="float"/></fig><fig position="float" id="viruses-16-01809-f005"><label>Figure 5</label><caption><p>CMV modulates monocyte cytokine production.</p></caption><graphic xlink:href="viruses-16-01809-g005" position="float"/></fig><fig position="float" id="viruses-16-01809-f006"><label>Figure 6</label><caption><p>CMV modulates monocyte migration and chemotaxis.</p></caption><graphic xlink:href="viruses-16-01809-g006" position="float"/></fig></floats-group></article>